CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP012297	Corynebacterium glutamicum strain B414, complete genome	4 crisprs	DEDDh,csa3,cas3,WYL,PrimPol,RT,DinG	0	1	0	0

Cas Category Instructions

Results visualization

1. NZ_CP012297

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP012297_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012297_1

256878-256990

Orphan

Consensus_repeat	Method
CCGGGGTGGTCTGTTTTGGCGGGGAGTCCGCCTTGTTTGG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012297_1

>merge|NZ_CP012297|1|256878-256990|CRISPRCasFinder
CCGGGGTGGTCTGTTTTGGCGGGGAGTCCGCCTTGTTTGGGACACCAGCGAACGAAAGTGGGCGGGCTTGGTGCCGGGGTGGTCTGTTTTGGCGGGGAGTCCGCCTTGCTTGG

>NZ_CP012297|1|1|256878-256990|CRISPRCasFinder
CCGGGGTGGTCTGTTTTGGCGGGGAGTCCGCCTTGTTTGG	GACACCAGCGAACGAAAGTGGGCGGGCTTGGTG
CCGGGGTGGTCTGTTTTGGCGGGGAGTCCGCCTTGCTTGG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012297.1\|WP_074492748.1\|252706_253603_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|377943
NZ_CP012297.1\|WP_074492752.1\|257226_258018_-\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|224057
NZ_CP012297.1\|WP_003857637.1\|262016_262298_+\|(2Fe-2S)-binding-protein	unknown	unknown	gnl\|CDD\|223706
NZ_CP012297.1\|WP_003857658.1\|253618_254053_+\|GtrA-family-protein	unknown	unknown	gnl\|CDD\|225155
NZ_CP012297.1\|WP_074492756.1\|260239_261220_-\|NAD(P)H-quinone-oxidoreductase	unknown	unknown	gnl\|CDD\|176180
NZ_CP012297.1\|WP_074492758.1\|261216_261744_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378933
NZ_CP012297.1\|WP_011896532.1\|249931_251398_-\|FAD-binding-oxidoreductase	unknown	unknown	gnl\|CDD\|223354
NZ_CP012297.1\|WP_003857656.1\|254063_254468_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074492764.1\|264441_265335_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379128
NZ_CP012297.1\|WP_074492762.1\|263876_264125_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074492754.1\|259037_260243_+\|aminotransferase-class-V-fold-PLP-dependent-enzyme	unknown	unknown	gnl\|CDD\|223594
NZ_CP012297.1\|WP_074492746.1\|252225_252681_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_011013459.1\|251737_252229_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074469823.1\|258028_258934_-\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|224596
NZ_CP012297.1\|WP_074492750.1\|254469_255105_+\|MOSC-domain-containing-protein	unknown	unknown	gnl\|CDD\|225167
NZ_CP012297.1\|WP_074492760.1\|262294_263782_-\|sodium:alanine-symporter-family-protein	unknown	unknown	gnl\|CDD\|224040
NZ_CP012297.1\|WP_038582121.1\|256055_256655_-\|VOC-family-protein	unknown	unknown	gnl\|CDD\|379203
NZ_CP012297.1\|WP_074492806.1\|255101_256034_-\|glycosyltransferase-family-2-protein	unknown	unknown	gnl\|CDD\|224137
NZ_CP012297.1\|WP_003857667.1\|251474_251702_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074492765.1\|265326_266400_-\|molybdopterin-biosynthesis-protein-MoeB	unknown	unknown	gnl\|CDD\|235526

Protein	Function_ID	Function_description	E-value
NZ_CP012297.1\|WP_074492748.1\|252706_253603_+\|hypothetical-protein	gnl\|CDD\|377943	pfam07929, PRiA4_ORF3, Plasmid pRiA4b ORF-3-like protein. Members of this family are similar to the protein product of ORF-3 found on plasmid pRiA4 in the bacterium Agrobacterium rhizogenes. This plasmid is responsible for tumorigenesis at wound sites of plants infected by this bacterium, but the ORF-3 product does not seem to be involved in the pathogenetic process. Other proteins found in this family are annotated as being putative TnpR resolvases, but no further evidence was found to back this. Moreover, another member of this family is described as a probable lexA repressor and in fact carries a LexA DNA binding domain (pfam01726), but no references were found to expand on this.	0.000580236
NZ_CP012297.1\|WP_074492752.1\|257226_258018_-\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|224057	COG1134, TagH, ABC-type polysaccharide/polyol phosphate transport system, ATPase component [Carbohydrate transport and metabolism / Cell envelope biogenesis, outer membrane].	7.53466e-120
NZ_CP012297.1\|WP_003857658.1\|253618_254053_+\|GtrA-family-protein	gnl\|CDD\|225155	COG2246, COG2246, Predicted membrane protein [Function unknown].	3.35176e-27
NZ_CP012297.1\|WP_074492756.1\|260239_261220_-\|NAD(P)H-quinone-oxidoreductase	gnl\|CDD\|176180	cd05276, p53_inducible_oxidoreductase, PIG3 p53-inducible quinone oxidoreductase. PIG3 p53-inducible quinone oxidoreductase, a medium chain dehydrogenase/reductase family member, acts in the apoptotic pathway. PIG3 reduces ortho-quinones, but its apoptotic activity has been attributed to oxidative stress generation, since overexpression of PIG3 accumulates reactive oxygen species. PIG3 resembles the MDR family member quinone reductases, which catalyze the reduction of quinone to hydroxyquinone. NAD(P)(H)-dependent oxidoreductases are the major enzymes in the interconversion of alcohols and aldehydes or ketones. Alcohol dehydrogenase in the liver converts ethanol and NAD+ to acetaldehyde and NADH, while in yeast and some other microorganisms ADH catalyzes the conversion acetaldehyde to ethanol in alcoholic fermentation. ADH is a member of the medium chain alcohol dehydrogenase family (MDR), which has a NAD(P)(H)-binding domain in a Rossmann fold of a beta-alpha form. The NAD(H)-binding region is comprised of 2 structurally similar halves, each of which contacts a mononucleotide. A GxGxxG motif after the first mononucleotide contact half allows the close contact of the coenzyme with the ADH backbone. The N-terminal catalytic domain has a distant homology to GroES. These proteins typically form dimers (typically higher plants, mammals) or tetramers (yeast, bacteria), and have 2 tightly bound zinc atoms per subunit, a catalytic zinc at the active site, and a structural zinc in a lobe of the catalytic domain. NAD(H) binding occurs in the cleft between the catalytic and coenzyme-binding domains at the active site, and coenzyme binding induces a conformational closing of this cleft. Coenzyme binding typically precedes and contributes to substrate binding. In human ADH catalysis, the zinc ion helps coordinate the alcohol, followed by deprotonation of a histidine, the ribose of NAD, a serine, then the alcohol, which allows the transfer of a hydride to NAD+, creating NADH and a zinc-bound aldehyde or ketone. In yeast and some bacteria, the active site zinc binds an aldehyde, polarizing it, and leading to the reverse reaction.	1.74561e-160
NZ_CP012297.1\|WP_074492758.1\|261216_261744_-\|hypothetical-protein	gnl\|CDD\|378933	pfam12725, DUF3810, Protein of unknown function (DUF3810). This family of proteins is functionally uncharacterized. This family of proteins is found in bacteria. Proteins in this family are typically between 333 and 377 amino acids in length. There is a conserved HEXXH sequence motif that is characteristic of metallopeptidases. This family may therefore belong to an as yet uncharacterized family of peptidase enzymes.	0.00343524
NZ_CP012297.1\|WP_011896532.1\|249931_251398_-\|FAD-binding-oxidoreductase	gnl\|CDD\|223354	COG0277, GlcD, FAD/FMN-containing dehydrogenases [Energy production and conversion].	4.78414e-60
NZ_CP012297.1\|WP_074492764.1\|264441_265335_+\|hypothetical-protein	gnl\|CDD\|379128	pfam13338, AbiEi_4, Transcriptional regulator, AbiEi antitoxin. AbiEi_4 is the cognate antitoxin of the type IV toxin-antitoxin 'innate immunity' bacterial abortive infection (Abi) system that protects bacteria from the spread of a phage infection. The Abi system is activated upon infection with phage to abort the cell thus preventing the spread of phage through viral replication. There are some 20 or more Abis, and they are predominantly plasmid-encoded lactococcal systems. TA, toxin-antitoxin, systems on plasmids function by killing cells that lose the plasmid upon division. AbiE phage resistance systems function as novel Type IV TAs and are widespread in bacteria and archaea. The cognate antitoxin is pfam13338.	2.28815e-05
NZ_CP012297.1\|WP_074492765.1\|265326_266400_-\|molybdopterin-biosynthesis-protein-MoeB	gnl\|CDD\|235526	PRK05597, PRK05597, molybdopterin biosynthesis protein MoeB; Validated.	0
NZ_CP012297.1\|WP_074492754.1\|259037_260243_+\|aminotransferase-class-V-fold-PLP-dependent-enzyme	gnl\|CDD\|223594	COG0520, csdA, Selenocysteine lyase/Cysteine desulfurase [Posttranslational modification, protein turnover, chaperones].	2.37951e-64
NZ_CP012297.1\|WP_003857637.1\|262016_262298_+\|(2Fe-2S)-binding-protein	gnl\|CDD\|223706	COG0633, Fdx, Ferredoxin [Energy production and conversion].	7.41524e-16
NZ_CP012297.1\|WP_074469823.1\|258028_258934_-\|ABC-transporter-permease	gnl\|CDD\|224596	COG1682, TagG, ABC-type polysaccharide/polyol phosphate export systems, permease component [Carbohydrate transport and metabolism / Cell envelope biogenesis, outer membrane].	5.48127e-71
NZ_CP012297.1\|WP_074492750.1\|254469_255105_+\|MOSC-domain-containing-protein	gnl\|CDD\|225167	COG2258, COG2258, Uncharacterized protein conserved in bacteria [Function unknown].	4.43812e-72
NZ_CP012297.1\|WP_074492760.1\|262294_263782_-\|sodium:alanine-symporter-family-protein	gnl\|CDD\|224040	COG1115, AlsT, Na+/alanine symporter [Amino acid transport and metabolism].	0
NZ_CP012297.1\|WP_038582121.1\|256055_256655_-\|VOC-family-protein	gnl\|CDD\|379203	pfam13468, Glyoxalase_3, Glyoxalase-like domain. This domain is related to the Glyoxalase domain pfam00903.	2.88346e-35
NZ_CP012297.1\|WP_074492806.1\|255101_256034_-\|glycosyltransferase-family-2-protein	gnl\|CDD\|224137	COG1216, COG1216, Predicted glycosyltransferases [General function prediction only].	1.92212e-62

>NZ_CP012297.1|WP_038582121.1|256055_256655_-|VOC-family-protein
MGTQIDHIVIAAPNLEDLVSRFEKLTGVKAVAGGRHDTGTANALVPLKEPKGSYLELIGPDPEADAVTQDNFAIATTQSTEPRVAAWCVRPDDLEALAAKRGTQSQLMSRHTPEGTTLTWRLILPEPGVDFAPVPFAIDWLGSPHPSKVTEPQVSVHSFTVYGHSEPDELPEPAIFQEGKPLLELVLESPKGRVNLSDL
>NZ_CP012297.1|WP_074492806.1|255101_256034_-|glycosyltransferase-family-2-protein
MAQTTTRLQPGINVAAVIVTHNRVELLRHSLEVVANQTYPVKHIVVVDNGADPDVEKLVLEVAGDRAVYTPSRTNLGGGGGFAFGFLTALALGADAVWCADDDGRPEGPEVLKTLIDAASRHNLEEVSPVVCNADDPERLAFPLRRGLEWRRMRSELIDPANPEDDLLPGIASLFNGALISAYAMERIGVPDYRLFIRGDEVEYHRRLVRSGLPFGTCLTTAYLHPDGSDEFKPILGGRMHTQYPDNDFKRFFTYRNRGYLMSQPGMRKLLPQEYARFAWFFLVQKRDVKGFREWLRLHKLGREEKFSRP
>NZ_CP012297.1|WP_074492750.1|254469_255105_+|MOSC-domain-containing-protein
MPGLVLSTNVAHIQQDPGGDDRISGINKLPVATGIDVFIPGPNYGDGSGVVGDAIGDSVHHGGAHKAIYAYSREELDFFDPTYRNGYFGENLTTSGIVLEDLLINQQVRIGTTLLEVSIPRRPCRTFAHWLDIKGWLKTFTQRGLPGSYFRVIEEGHINPGDPIEVLQAPDHDITMSMAFRAKMGNKDLARRVVAANCLPARYHEELLKLI
>NZ_CP012297.1|WP_003857656.1|254063_254468_+|hypothetical-protein
MKTFNPTMIAGLIGVLYFVLLTLIFSIQDMELAAEIAFGIVTIVGLIAVWDNFRDRNNSTWKTWTGLVGGLLIAVPGICLLVGNLVLLAVDGNPSTMVNTLLSVAGIGAIFLLPIGIIMCLIAGFNRFYAALKV
>NZ_CP012297.1|WP_003857658.1|253618_254053_+|GtrA-family-protein
MPENPDVTIVRPMSLKTQAFRFILTGGLSAIVDLGLLSLLQLVFGLPVPVARTISFIAGTTTAYMINRRWTFQAESSTSRFLAVVALYGVTFLINIGLQTLCSALFENWGWNEAVAMVCAFVIAQGTGTVINFIVQRTIIFRVK
>NZ_CP012297.1|WP_074492748.1|252706_253603_+|hypothetical-protein
MPTNYARDNVISLASAREQRSGKPESKPELTLIVRATNVQADGEVHRQIGLNSAMSLDELHNVLNIVFGVGGEQSPWRFEDQFHQPSAPDTNLGELLPEPGDFLFYFWGLWQFNLQCVEMYPRDNGTPRALCIGGSGGLGDDFDQATINAELTGTDTIRDVLSGVRPEVIDLVDRTGVFDFIPLLQALDLKREPLIDATRHHTCRTLPVENSAEASDAFWSCVLALSCLGNDELFIEVIESTMSTLGWVADDGSPLRAPEITSACEASLKILAEIGGYGPEQLAPVDRLDIYRELMCF
>NZ_CP012297.1|WP_074492746.1|252225_252681_+|hypothetical-protein
MTYPVLSVLDNSGDHNIIWHVQTYPAALPTGAWIADEQQLTDLLKDTVVFLTPGSTAPENAPVATIEGVRVDVDKQVAEYNKHGIRLPSLGARTVEAQYRGEPEAEAAWRTAMELAEIAGGWLEIEAKRRARKALAEAFGAEVQPLPLDTE
>NZ_CP012297.1|WP_011013459.1|251737_252229_+|hypothetical-protein
MDTRMRLQVAAGSALIGAGVAVNDYVQSPVRRAISYGALALSGATVIAMGQDPTGERSIIAKDSATMVDQIRQEIGDLGVTPGPESDVDAITERGPLVTWLLLAVFVVAFFTLAYFSMRMDVAVMRRIAKFFEKRGASRPFTCTGMVYAAFIYAICELEARTK
>NZ_CP012297.1|WP_003857667.1|251474_251702_-|hypothetical-protein
MFERFKKAKAPEVHIAAERTNLPLNDFMTRLFAQELPLLDSTSRSEVYRLLREYDGPTISSQEEIPAEIRELMDL
>NZ_CP012297.1|WP_011896532.1|249931_251398_-|FAD-binding-oxidoreductase
MNSSHGTSSSGASAGAHGALPLEAQKLNGWGRTAPTTAEVLSTPDLDIIVDAVRQVAEQNDSKPDYLKRGVIARGMGRSYGDPAQNAGGLVIDMQPLNKIHSIDPDSAIVDVDGGVTLDQLMKAALPYGLWVPVLPGTRQVTIGGAIGPDIHGKNHHSAGSFGDHVVSMELLVADGRILHLEPEGTAEDPQGDLFWATVGGMGLTGIIVRARIRMTKTETAYFIADTDRTNNLEETVAFHSDGSEHNYTYSSAWFDVISPEPKLGRSTISRGSLATLAQLEELAPKLAKDPLKFNAPQLMKVPDIFPSWTLNKLTLSAVGVAYYAMGAPAKNQVKNLTQFYQPLDLIGEWNRGYGSKGFLQYQFVVPTEAVEPFKDIIRDMQKSGHYSALNVFKLFGPGNRAPLSYPMPGWNVCVDFPIRPGLGAFLDDLDKRVMEFGGRLYLAKESRTSAENFHAMYPGMEGWLKTRNEIDPTGVFASDMSRRLELS
>NZ_CP012297.1|WP_074492752.1|257226_258018_-|ABC-transporter-ATP-binding-protein
MVSIDTYNACVDFPIFDAKSRSMKKAFLGAAGGAIGRNQDNVVVVEALRDINLHLREGDRVGLVGHNGAGKSTLLRLLSGIYEPTRGSADIRGRVAPVFDLGVGMDPEISGYENIIIRGLFLGQTRKQMKAKMEEIADFTELGEYLSMPLRTYSTGMRIRLALGVVTSIEPEILLLDEGIGAVDAAFMAKARDRLQALVERSGILVFASHSNDFLAQLCNTALWVDHGQIRDAGLVPDIVESYEGKGAGDHVRRLLTRIEEEK
>NZ_CP012297.1|WP_074469823.1|258028_258934_-|ABC-transporter-permease
MSYVQEQSKQKDLQADIARITAVKSDTVPNSQSMTFGAAWNDIVRGFKQHELWLQLGWQDIKQRYRRSVLGPLWITIATGVMALALGLLYSVLFKIPIAEFLPHVTVGLIIWNFISGCIKEGSDIFIDNEGLIKQLPSALSVHVYRLVWKQALFLAHNLVIWVILMMIFPRPLGWDVLLIIPAMFLLVINGVWVVMFFGIIATRYRDVSPLLEAGTQLLFYVTPIVWMTSTLQSQSAEIGNRARLAELNPLYHYLEIVRAPMIGADLPAYHWWIVLAFTFVGLGLALLAMKQWRFRVSYWV
>NZ_CP012297.1|WP_074492754.1|259037_260243_+|aminotransferase-class-V-fold-PLP-dependent-enzyme
MLWRLKGVPFVGFDVARVRGLYTSLGDGWTYLNSHQIPQVPERVASGVAAAFRTHAQISEVTSRPIAVDQLEAAREAVASLAGVDPDCVVLGPTRQFLAHTLARGLGGFVRRKAGVVLSRADADWLTAPFRSLDGVFSWAEPDLGTGMLPDWQYEKLVDGSTRLVVLSAAHPLLGTVAPVGKIVDKVRARSRAWVLVDATTYAAYRPLRLDEWEADIVMLDLGELGGPQISALIFRDTSMFPRLDRTVPRELPASSLPHGLLGGVPNLVRHLGNLDENAPSVVEAMGEMAKFHKGLFEHLVESLEGLHAVHIVGISGDAAGQDAAFLDRVPRLTFTMEGVPADMVYRRLVDNRLVTTVSPADPLLEAMGVTEAGGSITIGLSPFSTYYEVDQLTRVLASLA
>NZ_CP012297.1|WP_074492756.1|260239_261220_-|NAD(P)H-quinone-oxidoreductase
MTEITRQTMQAIVQTEEKVTASLELQEVPVPALKPGEVLVEVKAAGVNRADLLQTQGNYPVPAGASEILGLECAGVIVDAGDTGQTVGQEVACLLTGGGYAEYVAVPEGQLMPIPEGYSFVEAASIVEVACTVWSNIGMLAGLQKEDTFLIHGGAGGIGTFAIQMGKALGVTVAVTAGSTEKLKTCKNLGADILINYKEEDFAEVLKNKADVILDIIGAKYLSQNVKAMAKDAHMVVIGMQGGVKGELNLGHLLAKRGTISATALRGRDEADKARIVSSTVENIWPLLQSKEITPHIDHTLPLAEAAAALQKIQDGTITGKLVLTV
>NZ_CP012297.1|WP_074492758.1|261216_261744_-|hypothetical-protein
MDMLKIAIIAAVMIGVPVLVVFLIVFAVHKLAKEVPRSGRRPGIGLGLLLGFVAGLIVWFVWLSWGGYYENEFGQMQGPYRPWQVVACGVTMVVVTVALGLWTRWTASGPFYSALGGTSGFSFAWAMDALPQDETGLSAFGLVMVIVGVGAGLNVVAAITSNSATNWNNRLPSNT
>NZ_CP012297.1|WP_003857637.1|262016_262298_+|(2Fe-2S)-binding-protein
MALHTHKIDGETYAFSWSPTQTLLDALLQADLPARYSCMEGHCGTCQCTLTGGPSHMLNNEVLSNYEIVSENQVLACQTIRDADGPYHCSFDD
>NZ_CP012297.1|WP_074492760.1|262294_263782_-|sodium:alanine-symporter-family-protein
MELLETFITDVINDNLWMILPFLLVAAGLYFGGRTLLVQIRMIPEMFKAVVEKPAKDGEFADKQDISAFKAFTISAASRVGTANVAGVALAITLGGPGAVFWMWIIALVGGATSFIESTLGQLWKVKDGDSYRGGPAYYMTLGLNARWLAVVFGVAITLTFGFVYNALQSNAVVEAITVSLGTPSTTAKAFVGLGMAGLSALVIFGGVQRIANVTQWMVPFMAGAYIIVGVVVIVINIQQVPTMINDIIAGAFGFRPVATASVWGAFWLAFMNGMRRGLFSNEAGEGSVPNAAATATVSHPVKQGLVQTLGVYFDTLLVCSITAFVILLSGVEYATGDIQSTSLTQSALASVVGGWGTHFITAVMFFLAFSSVLGNYYLAQANIQYFTDSKTVMTVFRLLVLLSVFSGAVASVPLIWALGDTFAGIMVLINLAAIIPLGGVAVKLLKNYTIQKKAGLDPVFHRDMMPEVRNIACWNGKDAATSNYHEAMEVIKKS
>NZ_CP012297.1|WP_074492762.1|263876_264125_-|hypothetical-protein
MQPFGRLIRPVSRAWIPARAKQGGFLDGKCYPRPKPALIDPPRAQQGKLARRSDHPELKPALFAPQRAKPGRLPSGAAHPGS
>NZ_CP012297.1|WP_074492764.1|264441_265335_+|hypothetical-protein
MWTAKELIGMGYSRRRINSLVKEGKLHRVLRGVYALDPPSGEVVWSAIRLVRPGALLDGKSAVEVYQGVSLSLPVRVRVSTSNVLRGSRNVVARRSQRMDGIAHRGFRVVSLVDTVATCLDERSVNPSDLRRLVEERYKSGSGVKQMAHDLKLLRTRRKAQLREFLEECIYGLDSGLEKVMVQELRDAGFRTRQNVVVEGYRWDIQVVGVALIDVDSRKYHQANGRNFIIDRWKSNEAVVQGHVPLRFTDDCVNYATGEIIKLVKQVAEFKRKHPRRRVKTQGVGPVFRWHNALVLP
>NZ_CP012297.1|WP_074492765.1|265326_266400_-|molybdopterin-biosynthesis-protein-MoeB
MKNLDIARYRRQIMLGEIGQQKQQSLFDAKVSVIGAGGLGSPALLYLAGAGVGHIHIIDDDLVDLSNLHRQVIHTTAGVGTPKAESAREAMLALNPSVKVTVSVRRLDWSNALSELADSDVILDGSDNFDTRHLASWAAAKLGIPHVWASILGFDAQLSVFHAGHGPIYEDLFPTPPPPGSVPSCSQAGVLGPVVGVMGSSMAMEALKIITGVGTPLIGKLGYYSSLDGTWEYIPVVGSPEVLERVLGSAGVSGISGGFGEVLDVPRVSALVDGVSLIDVREPSEFSAYSIPGAHNTPLSAIREGAIPPAVSAGKEVIVYCAAGVRSAQAIAILESAGYTGMSSLDGGIEGWLDSLG

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012297_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012297_2

848052-848158

Orphan

Consensus_repeat	Method
AACCGTCCTATATGACCGAAACTAAAAAGCTGGAGG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012297_2

>merge|NZ_CP012297|2|848052-848158|CRISPRCasFinder
AACCGTCCTATATGACCGAAACTAAAAAGCTGGAGGATTTTCGGTCACCTGGTGTGGTTTCGAGTGTTGAAAACCGTCCTATATGACCGAAACTAAAAAGCTCGAGG

>NZ_CP012297|2|2|848052-848158|CRISPRCasFinder
AACCGTCCTATATGACCGAAACTAAAAAGCTGGAGG	ATTTTCGGTCACCTGGTGTGGTTTCGAGTGTTGAA
AACCGTCCTATATGACCGAAACTAAAAAGCTCGAGG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012297.1\|WP_074492240.1\|838037_838910_+\|glycosyltransferase-family-2-protein	unknown	unknown	gnl\|CDD\|224137
NZ_CP012297.1\|WP_074491368.1\|854161_855868_+\|MtrAB-system-accessory-protein-LpqB	unknown	unknown	gnl\|CDD\|237449
NZ_CP012297.1\|WP_011013865.1\|846739_847924_+\|mannose-6-phosphate-isomerase,-class-I	unknown	unknown	gnl\|CDD\|380414
NZ_CP012297.1\|WP_038583061.1\|851249_851861_+\|dTMP-kinase	unknown	unknown	gnl\|CDD\|236133
NZ_CP012297.1\|WP_003858182.1\|856601_857267_+\|ribosome-associated-translation-inhibitor-RaiA	unknown	unknown	gnl\|CDD\|224461
NZ_CP012297.1\|WP_038583063.1\|851885_852566_+\|response-regulator-transcription-factor	unknown	unknown	gnl\|CDD\|223816
NZ_CP012297.1\|WP_040967100.1\|857405_859943_+\|preprotein-translocase-subunit-SecA	unknown	unknown	gnl\|CDD\|237259
NZ_CP012297.1\|WP_074491366.1\|852665_854165_+\|HAMP-domain-containing-histidine-kinase	unknown	unknown	gnl\|CDD\|223715
NZ_CP012297.1\|WP_074491364.1\|849813_851250_+\|adenosylhomocysteinase	unknown	unknown	gnl\|CDD\|377487
NZ_CP012297.1\|WP_003858196.1\|849349_849703_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074491370.1\|855867_856458_+\|ComF-family-protein	unknown	unknown	gnl\|CDD\|223970
NZ_CP012297.1\|WP_074491362.1\|848332_849106_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|223021
NZ_CP012297.1\|WP_074491360.1\|845731_846739_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_011013864.1\|843255_843660_-\|metallopeptidase-family-protein	unknown	unknown	gnl\|CDD\|240574
NZ_CP012297.1\|WP_003858209.1\|840558_840873_+\|WhiB-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|376791
NZ_CP012297.1\|WP_003863574.1\|844280_845657_+\|phosphomannomutase/phosphoglucomutase	unknown	unknown	gnl\|CDD\|236557
NZ_CP012297.1\|WP_074493920.1\|841873_843055_+\|IS3-family-transposase	unknown	unknown	gnl\|CDD\|366234
NZ_CP012297.1\|WP_034983597.1\|839082_840171_+\|NDP-sugar-synthase	unknown	unknown	gnl\|CDD\|224129
NZ_CP012297.1\|WP_145832261.1\|841061_841871_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_003863575.1\|843808_844201_+\|DUF3499-domain-containing-protein	unknown	unknown	gnl\|CDD\|378788

Protein	Function_ID	Function_description	E-value
NZ_CP012297.1\|WP_074492240.1\|838037_838910_+\|glycosyltransferase-family-2-protein	gnl\|CDD\|224137	COG1216, COG1216, Predicted glycosyltransferases [General function prediction only].	3.94511e-67
NZ_CP012297.1\|WP_074491368.1\|854161_855868_+\|MtrAB-system-accessory-protein-LpqB	gnl\|CDD\|237449	PRK13616, PRK13616, MtrAB system accessory protein LpqB.	0
NZ_CP012297.1\|WP_011013865.1\|846739_847924_+\|mannose-6-phosphate-isomerase,-class-I	gnl\|CDD\|380414	cd07011, cupin_PMI_type_I_N, type I phosphomannose isomerase in eukaryotes and bacteria, N-terminal cupin domain. This subfamily contains type I phosphomannose isomerase (PMI; E.C. 5.3.1.8; also known as mannose-6-phosphate isomerase) found in eukaryotes and some bacteria such as Salmonella enterica. PMI catalyzes the reversible isomerization of fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P), the first committed step in the synthesis of mannosylated glycoproteins. The active site, located within the N-terminal jelly roll-like beta-barrel cupin fold, contains a single essential zinc atom and forms a deep, open cavity large enough to contain M6P or F6P. PMI type I also has a C-terminal beta-barrel fold which has diverged considerably from the N-terminal domain and is not included here. This subfamily contains an alpha helical domain that is found in eukaryotic and some prokaryotic PMIs but is not present in their archaeal counterparts. F6P is a substrate for glycolysis and gluconeogenesis, while M6P is a substrate for production of activated mannose donor guanosine 5'-diphosphate D-mannose, an important precursor of mannosylated biomolecules such as glycoproteins, bacterial exopolysaccharides and fungal cell wall components. PMI is also essential for survival, virulence and possibly pathogenicity of some bacteria and protozoan parasites, as well as for cell wall integrity of certain yeasts. Thus, PMI is a potential target against fungal infections causing serious illness or death.	3.05639e-98
NZ_CP012297.1\|WP_038583061.1\|851249_851861_+\|dTMP-kinase	gnl\|CDD\|236133	PRK07933, PRK07933, dTMP kinase.	4.18158e-101
NZ_CP012297.1\|WP_003858182.1\|856601_857267_+\|ribosome-associated-translation-inhibitor-RaiA	gnl\|CDD\|224461	COG1544, COG1544, Ribosome-associated protein Y (PSrp-1) [Translation, ribosomal structure and biogenesis].	1.09912e-29
NZ_CP012297.1\|WP_038583063.1\|851885_852566_+\|response-regulator-transcription-factor	gnl\|CDD\|223816	COG0745, OmpR, Response regulators consisting of a CheY-like receiver domain and a winged-helix DNA-binding domain [Signal transduction mechanisms / Transcription].	7.33976e-90
NZ_CP012297.1\|WP_040967100.1\|857405_859943_+\|preprotein-translocase-subunit-SecA	gnl\|CDD\|237259	PRK12904, PRK12904, preprotein translocase subunit SecA; Reviewed.	0
NZ_CP012297.1\|WP_074491366.1\|852665_854165_+\|HAMP-domain-containing-histidine-kinase	gnl\|CDD\|223715	COG0642, BaeS, Signal transduction histidine kinase [Signal transduction mechanisms].	1.6988e-53
NZ_CP012297.1\|WP_003863575.1\|843808_844201_+\|DUF3499-domain-containing-protein	gnl\|CDD\|378788	pfam12005, DUF3499, Protein of unknown function (DUF3499). This family of proteins is functionally uncharacterized. This protein is found in bacteria. Proteins in this family are typically between 125 to 163 amino acids in length.	3.83221e-60
NZ_CP012297.1\|WP_074491370.1\|855867_856458_+\|ComF-family-protein	gnl\|CDD\|223970	COG1040, ComFC, Predicted amidophosphoribosyltransferases [General function prediction only].	1.0877e-28
NZ_CP012297.1\|WP_074491362.1\|848332_849106_-\|hypothetical-protein	gnl\|CDD\|223021	PHA03247, PHA03247, large tegument protein UL36; Provisional.	3.32775e-06
NZ_CP012297.1\|WP_011013864.1\|843255_843660_-\|metallopeptidase-family-protein	gnl\|CDD\|240574	cd12954, MMP_TTHA0227_like_1, Minimal MMP-like domain found in a group of hypothetical proteins from alphaproteobacteria and actinobacteria. The subfamily includes some uncharacterized bacterial proteins which show high sequence similarity with Thermus thermophilus hypothetical protein TTHA0227. However, they do not contain the conserved HExxH (x could be any amino acid) motif. They may not have any zinc metallo-peptidase activity.	6.61282e-24
NZ_CP012297.1\|WP_003858209.1\|840558_840873_+\|WhiB-family-transcriptional-regulator	gnl\|CDD\|376791	pfam02467, Whib, Transcription factor WhiB. WhiB is a putative transcription factor in Actinobacteria, required for differentiation and sporulation.	9.78845e-31
NZ_CP012297.1\|WP_003863574.1\|844280_845657_+\|phosphomannomutase/phosphoglucomutase	gnl\|CDD\|236557	PRK09542, manB, phosphomannomutase/phosphoglucomutase; Reviewed.	0
NZ_CP012297.1\|WP_074493920.1\|841873_843055_+\|IS3-family-transposase	gnl\|CDD\|366234	pfam00665, rve, Integrase core domain. Integrase mediates integration of a DNA copy of the viral genome into the host chromosome. Integrase is composed of three domains. The amino-terminal domain is a zinc binding domain pfam02022. This domain is the central catalytic domain. The carboxyl terminal domain that is a non-specific DNA binding domain pfam00552. The catalytic domain acts as an endonuclease when two nucleotides are removed from the 3' ends of the blunt-ended viral DNA made by reverse transcription. This domain also catalyzes the DNA strand transfer reaction of the 3' ends of the viral DNA to the 5' ends of the integration site.	2.23389e-26
NZ_CP012297.1\|WP_034983597.1\|839082_840171_+\|NDP-sugar-synthase	gnl\|CDD\|224129	COG1208, GCD1, Nucleoside-diphosphate-sugar pyrophosphorylase involved in lipopolysaccharide biosynthesis/translation initiation factor 2B, gamma/epsilon subunits (eIF-2Bgamma/eIF-2Bepsilon) [Cell envelope biogenesis, outer membrane / Translation, ribosomal structure and biogenesis].	1.40886e-114
NZ_CP012297.1\|WP_074491364.1\|849813_851250_+\|adenosylhomocysteinase	gnl\|CDD\|377487	pfam05221, AdoHcyase, S-adenosyl-L-homocysteine hydrolase.	0

>NZ_CP012297.1|WP_011013865.1|846739_847924_+|mannose-6-phosphate-isomerase,-class-I
MELLEGSLRTYPWGSRTLIADLKGEESPSSRPEAEVWFGAHPGSPSTIGGNALNEVIAANPEEALGTRVAEAFENELPFLLKILAAGAPLSLQAHPSLEQAREGFARENSAGIDLGAPNRNYRDPNHKPELIVALTEFIAMAGFRPLRNTLTIFDALACEPLDRYRSMLTVDNEEESLRALFTTWITIPIGKRHELIDALISNAHTYLEASDRDEDIAFVLSHIIELNEQYPGDVGVLGALLLNFYKLAPGEALYLDAANLHAYISGLGVEIMANSDNVLRGGLTSKYVDVPELVRVLDFNSLENARVDVEEDGATTHYPVPINEFQLDRVAVQGEAEANHDGPMIVLCTSGTVSLEAGEKTLEVAAGHAAWVPANDPTIAMRSEDAEVFLARV
>NZ_CP012297.1|WP_074491360.1|845731_846739_+|hypothetical-protein
MVQVDNTFYDGSAYDPETVRFFDVAQEGAQVRLIGGLVAQGALSAFEGLRPRSVVVMIDGQIHRSCVRLVETLHSPMRQPLVITSTLPHYIGALDVLIVITDNGADEKALKALITASQRGVATLLIGPSSGPLIDESPQDTFVLPTLPTAAGLSPARIVASISTLLDLLEADPSIISDRLEHLADCIDEEVESLSPERDELVNPGRKLRAYVDHARIVHTGRTDVGLAIANVIAPIWTRRGLVSAVLDFPELMESLPELRGPEPITDDIFHDPFIDDEPGVVPFRAVVWAEEEPGIPDAMAQSCDGPSKGALTQALRLLVRGQSATTYSIEEKDL
>NZ_CP012297.1|WP_003863574.1|844280_845657_+|phosphomannomutase/phosphoglucomutase
MRTRESVTAVIKAYDVRGVVGVDIDADFISETGAAFGRLMRSEGETTVAIGHDMRDSSPELAKAFADGVTAQGLDVVHLGLTSTDELYFASGTLKCAGAMFTASHNPAEYNGIKLCRAGARPVGQDSGLANIIDDLVEGVPAFDGESGSVSEQDLLSAYAEYLNELVDLKNIRPLKVAVDAANGMGGFTVPEVFKGLPLDVAPLYFELDGNFPNHEANPLEPANLVDLQKFTVETGSDIGLAFDGDADRCFVVDEKGQPVSPSAICAIVAERYLEKLPGSTIIHNLITSKAVPEVIAENGGTAVRTRVGHSFIKAKMAETGAAFGGEHSAHYYFTEFFNADSGILAAMHVLAALGSQDQPLSEMMARYNRYVASGELNSRLANAEAQQERTQAVLDAFADRTESVDTLDGVTVELKDTSAWFNVRASNTEPLLRLNVEAASKEEVDALVAEILGIIRA
>NZ_CP012297.1|WP_003863575.1|843808_844201_+|DUF3499-domain-containing-protein
MSQFRRCSRPGCGKPAVATLTYAYSDSTAVVGPLAPAAEPHSWDLCEHHAERITAPLGWEMLRVNDIKVDDDEDLTALAQAVREAGRTVSGLVPEDEVGGNHPVNRSARIAEQKVHRRGHLYVVPDQDES
>NZ_CP012297.1|WP_011013864.1|843255_843660_-|metallopeptidase-family-protein
MPVEVPRHASRRQAFDRAVLEAYSPLYGIYQKELSNLDIAVDTVPRMRLSADLAILPDEITADGPVPLGRVIPPAIDTKGNPTRARIVIFRMPIEQRVTNAVERHELLTHVLTSLVANYLNIDPRDIDPGFQDL
>NZ_CP012297.1|WP_074493920.1|841873_843055_+|IS3-family-transposase
MDEQRAFDQGLKEENTLITDLTTCARLSHNKALRLIKLSKSTAYYRNKPRPRPAPKPVLQAVPAPTAPGVELAAPGVEPTPEPWQGKEPAVSSVRQALAEHERQFIVDAITAYPQLSVSGVFNMLFNKGIYRASLRTWWRVAKQHKLLHKDRVSALSPVKRSPTPRVKPRLEATQPGQVVCWDVTFLPSLVRGKTYALHLAIDLFSRKIVGAKVAPTENTSTAVELLTQVLADNPGVVTVHSDNGSAMTSTRVRRLLADHGVALSLIRPRVSDDNAFVESVFHTLKYRPFYPKVFASMDQARVWVEEFVVYYNTVHPHSGVAGHTPQSVFDGSWRAAHRLRVQALDAHYRQFPQRYVGRPVVQEVAGVVRLNGARDDGSVQERVGGVASLLSA
>NZ_CP012297.1|WP_145832261.1|841061_841871_+|hypothetical-protein
MSIPFSVLQDYLDLISPEALPQIPQPPAPAPTAPQLPPAPDPHSIEWPIFPPDRISPNGRRYYEPQTRLEFMRIYTTLPHGYRQPFLKANNIGHCTVRTWLAAISTFSRLPHAFDDAHRFGIERTTPVDDVTTLTADDKRDLVIGYLAQPHGQGQQFLTFYQLRKHTIMAWCAAMTDGDLDADVYPRKIGLMTTRTVVEIVRLRHMIAQQLERATIMENEYLKEIAALKKELAHYKQKDHQNQMVIDILGKAIGTRPNPGEGLDEEDAT
>NZ_CP012297.1|WP_003858209.1|840558_840873_+|WhiB-family-transcriptional-regulator
MEDSAGDVSAKLKAGQTRTALEMTLDDLFGAVEQEWQEQALCAQTDPEAFFPEKGGSTREAKRICQGCPVRDECLEFALEHDERFGIWGGLSERERRRLKREIS
>NZ_CP012297.1|WP_034983597.1|839082_840171_+|NDP-sugar-synthase
MTLTDNSKNVDAVILVGGKGTRLRPLTVNTPKPMLPTAGHPFLTHLLARIKAAGITHVVLGTSFKAEVFEEYFGDGSEMGLEIEYVVEDQPLGTGGGIRNVYDKLRHDTAIVFNGDVLSGADLSSILDTHREKEADLTMHLVRVANPRAFGCVPTDEDGRVSEFLEKTEDPPTDQINAGCYVFKKELIEQIPAGRVVSVERETFPQLLEEGKRVFGHVDASYWRDMGTPSDFVRGSADLVRGIAYSPLLEGKTGESLVDASAGVRDGVLLLGGTVVGRGTEIGAGCRVDNTVIFDGVTIEPGAVIENSIISSGARIGANAHISGCIIGEGAQVGARCELNAGMRVFPGVVIPDSGIRFSSDQ
>NZ_CP012297.1|WP_074492240.1|838037_838910_+|glycosyltransferase-family-2-protein
MITVTYSPGKYLASFLDSLPGATSRDTHVVMADNGSVDGVPEQAAASRSNVEFLSTGGNLGYGTAINIAARSLRARREAGEIDGEFFLVSNPDVVFDEGSIDQLLECAKRHPEAGSVGPLIREADGSVYPSARAVPTLANGIGHALLGAVWKSNPWSAAYRDDEDMDTERTAGWLSGSCLLLRWDAFDQVGGFDERYFMYMEDVDLGDRLVRAGFTNVFCPSAQIIHAKGHVAGKNPENMLPAHHESAYRFQADRLAKPWQAPIRLALRIGLKLRAGVAVGVSKMRTKAS
>NZ_CP012297.1|WP_074491362.1|848332_849106_-|hypothetical-protein
MKTETRRALVFIVAGCLAATALGFMVWQMSSPSRPTSDIATSTTTSTTQTQARYDSPGNTETKEAEPDLENQTLAPINTEDPYLPPNAFVRPDNGRSSGLTPSGSSPTTTSRVSSPSSAGSASPTQITSRSNEPSEPGDESTAATQPSSPDRPTEPTNPVDPTGPSEPTEPTDPIETTDPIETTDPVAPSTPPTSDDSTSTPQPDESDTPPTDFVEEPTAPLNPDQPAGSTTDATPNAPADTTSNSVANSVEPTATS
>NZ_CP012297.1|WP_003858196.1|849349_849703_+|hypothetical-protein
MGAWDDAILTEEVNVDFLDEISELDTQDILEALEDACLLVVNQDNATEDEHLNGQAAATIAAIMFGAPYSAGQVLENYPFIRELVGEGSEALRGAAAQVLEEADVEYDLEAYLEALN
>NZ_CP012297.1|WP_074491364.1|849813_851250_+|adenosylhomocysteinase
MAQVMDFKVADLSLAEAGRHQIRLAEYEMPGLMQLRKEFADEQPLKGARIAGSIHMTVQTAVLIETLTALGAEVRWASCNIFSTQDEAAAAIVVGSGTVEEPAGVPVFAWKGESLEEYWWCINQIFSWGDELPNMILDDGGDATMAVIRGREYEQAGLVPPAEANDSDEYIAFLGMLREVLAAEPGKWGKIAEAVKGVTEETTTGVHRLYHFAEEGVLPFPAMNVNDAVTKSKFDNKYGTRHSLIDGINRATDMLMGGKNVLVCGYGDVGKGCAEAFDGQGARVKVTEADPINALQALMDGYSVVTVDEAIEDADIVITATGNKDIISFEQMLKMKDHALLGNIGHFDNEIDMHSLLHRDDVTRTTIKPQVDEFTFSTGRSIIVLSEGRLLNLGNATGHPSFVMSNSFADQTIAQIELFQNQGQYENEVYRLPKVLDEKVARIHVEALGGQLTELTKEQAEYIGVDVAGPFKPEHYRY
>NZ_CP012297.1|WP_038583061.1|851249_851861_+|dTMP-kinase
MIVSIEGIDGAGKNTLVSALTQVIDAKVLAFPRYETSIHAQLAAEALHGRMGDLTDSAYAMATLFALDRHFAIDDLNAPGVVLLDRYVASNAAYTAARLLDDDAPRWVADLEFGRLGLPRPTLQVLLDTPAEVAQDRARRREALDSARARDRYESDAALQQRTAEHYRRLAADNWESPWIVVAPDEDPGHVAQRIVEFLGTIN
>NZ_CP012297.1|WP_038583063.1|851885_852566_+|response-regulator-transcription-factor
MSQKILVVDDDPAISEMLTIVLSAEGFDTVAVTDGALAVETASREQPDLILLDLMLPGMNGIDICRLIRQESSVPIIMLTAKTDTVDVVLGLESGADDYVNKPFKAKELVARIRARLRATVDEPSEILEVGDLSIDVPAHTVKRNGAEISLTPLEFDLLLELARKPQQVFTREELLGKVWGYRHASDTRLVNVHVQRLRAKIEKDPENPQIVLTVRGVGYKTGHND
>NZ_CP012297.1|WP_074491366.1|852665_854165_+|HAMP-domain-containing-histidine-kinase
MLGSIFTASAVVMILLGLGMLTVFTQRLVDQKIDIASSEIDRARVIVEEQITASGASTSVQARVNSARAALSSLGTSGGTETNAAYDPVVLVNNDDLVVSPEGYQIPERLRYFVSENQVSYQFSSIDQGDGSSYQALIIGTPTESDIPNLQVYLVFSMESDESSLALMRGLLSAALLIVVVLLVGIAWLATQQVTAPVRSASRIAERFAQGKLRERMVVEGEDEMARLAVSFNAMAESLSAQITKLEEYGNLQRQFTSDVSHELRTPLTTVRMAADLIADSEDELSPGARRASQLMTRELDRFESLLSDLLEISRHDAGVAELSTALHDVRIPVRSALEQVQHLATELDVELLVDLPEEAINIQGDSRRIERIIRNLLANAIDHSKGLPVELKVADNEDAVAIVVIDHGVGLKPGQDELVFNRFWRADPSRVRHSGGTGLGLAISREDAMLHGGNLDAAGTIGVGSIFRLVLPKEPHGNYREAPIPLIAPETPWEGDQQ
>NZ_CP012297.1|WP_074491368.1|854161_855868_+|MtrAB-system-accessory-protein-LpqB
MSKISTKLKTLTAVLSVTTLVAGCSTLPQNTDPQVLRSFSGSQSTQEIAGPTPNQDPDLLIRGFFSAGAYPTQQYEAAKAYLTEGTRSTWNPAASTRILDRIDLNTLPGSTNAERTIAIRGTQVGTLLSGGVYQPENAEFEAEITMRREDGEWRIDALPDGILLERNDLRNHYTPRDVYFFDPSGQVLVGDRRWLFNESQSMSTVLMALLVNGPSPAISPGVVNQLSTDASFVGFNDGEYQFTGLGNLDDDARLRFAAQAVWTLAHADVAGPYTLVADGAPLLSEFPTLTTDDLAEYNPEAYTNTVSTLFALQDGSLSRVSSGNVSPLQGIWSGGDIDSAAISSSANVVAAVRHESNEAVLTVGSMEGVTSDVLRSETITRPTFEYASSGLWAVVDGETPVRVARSATTGELVQTEAEIVLPRDVTGPISEFQLSRTGVRAAMIIEGKVYVGVVTRPGPGERRVTNITEVAPSLGEAALSINWRPDGILLVGTSIPETPLWRVEQDGSAISSMPSGNLSAPVVAVASSATTIYVTDSHAMLQLPTADNDIWREVPGLLGTRAAPVVAY
>NZ_CP012297.1|WP_074491370.1|855867_856458_+|ComF-family-protein
MELFFPRACGGCGAPGASLCSDCQRVWRKPPTLARLDLDVPVWTLSPYDGPHRNVLIALKEHGRADLVAFVGAVVGASISYLAAQGEVEHDITLVPAPTRATSRRRRGGDPVERVCNASRLSTFPCLQISSRTPDSVGQTAQQRRLNMRVELVRQPRGSVLIIDDVVTTGATISASANVLRAAGVQVRGALTYCQA
>NZ_CP012297.1|WP_003858182.1|856601_857267_+|ribosome-associated-translation-inhibitor-RaiA
MTTPAENNTLSPETKVSITGRNVEVPDHFAERVNTKLAKIERLDPTLTFFHVELQHEPNPRRADESDRIQITATGKGHIARAEAKEDSFYAALETALAKMERSLRKVKARRSISRSGHRAPLGTGEVGAQLVAESQEARGADELGKYDVDPYADKVDDVMPGQVVRTKEHPATPMSVDDALSEMELVGHDFYLFVNEETNQPSVVYRRHAFDYGLISLSDA
>NZ_CP012297.1|WP_040967100.1|857405_859943_+|preprotein-translocase-subunit-SecA
MFGLSKVLRVGEGRAVKRLHKIADQVIALEEKFANLTDEELKAKTAEFKERIAGGEGLDEIFLEAFATAREASWRVLGQKHYPVQIMGGAALHFGNVAEMRTGEGKTLTCVLPAYLNALEGKGVHVVTVNDYLAKRDAEMVGRVHRYLGLEVGVILSDMRPDERRKAYTADITYGTNNELGFDYLRDNMARSLSDLVQRGHNYAIVDEVDSILIDEARTPLIISGPVDGTSQFYNVFAQIVPRMTKDVHYEVDERKKTVGVKEEGVEYVEDQLGIDNLYAPEHSQLVSYLNNAIKAQELFTRDKDYIVRNGEVMIVDGFTGRVLAGRRYNEGMHQAIEAKERVEIKNENQTLATVTLQNYFRLYTKLAGMTGTAETEAAELNQIYKLDVIAIPTNRPNQREDLTDLVYKTQEAKFAAVVDDIAERTEKGQPVLVGTVSVERSEYLSQLLTKRGIKHNVLNAKHHEQEAQIVAQAGLPGAVTVATNMAGRGTDIVLGGNPEILLDIKLRERGLDPFEDEESYQEAWDAELPAMKQRCEERGDKVREAGGLYVLGTERHESRRIDNQLRGRSARQGDPGSTRFYLSMRDDLMVRFVGPTMENMMNRLNVPDDVPIESKTVTNSIKGAQAQVENQNFEMRKNVLKYDEVMNEQRKVIYSERREILESADISRYIQNMIEETVSAYVDGATANGYVEDWDLDKLWNALEALYDPSINWTDLVEGSEYGKPGELSAEDLRTALVNDAHAEYAKLEEAVSAIGGEAQIRNIERMVLMPVIDTKWREHLYEMDYLKEGIGLRAMAQRDPLVEYQKEGGDMFNGMKDGIKEETVRQLFLLRKQFIKQDAEVAD

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012297_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012297_3

1457264-1457360

Orphan

Consensus_repeat	Method
TTTGGCACGTGTGTCCGGTTATGAG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012297_3

>merge|NZ_CP012297|3|1457264-1457360|CRISPRCasFinder
TTTGGCACGTGTGTCCGGTTATGAGTGGTTGAAACCGGACTGGCGTGCCAAGAGAAGGCCGAAATTCAAAGTTTTGGCACGTGTGTCCGGTTTGAGG

>NZ_CP012297|3|3|1457264-1457360|CRISPRCasFinder
TTTGGCACGTGTGTCCGGTTATGAG	TGGTTGAAACCGGACTGGCGTGCCAAGAGAAGGCCGAAATTCAAAGT
TTTGGCACGTGTGTCCGGTTTGAGG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012297.1\|WP_074494069.1\|1457775_1460418_+\|DNA-polymerase-I	unknown	unknown	gnl\|CDD\|235591
NZ_CP012297.1\|WP_074494067.1\|1455080_1455890_+\|DUF1266-domain-containing-protein	unknown	unknown	gnl\|CDD\|377728
NZ_CP012297.1\|WP_074494074.1\|1469300_1469903_+\|dephospho-CoA-kinase	unknown	unknown	gnl\|CDD\|237808
NZ_CP012297.1\|WP_074494073.1\|1467229_1469290_+\|PTS-transporter-subunit-EIIC	unknown	unknown	gnl\|CDD\|273919
NZ_CP012297.1\|WP_074494068.1\|1455972_1456953_-\|DUF368-domain-containing-protein	unknown	unknown	gnl\|CDD\|224946
NZ_CP012297.1\|WP_038583872.1\|1451161_1451644_+\|pantetheine-phosphate-adenylyltransferase	unknown	unknown	gnl\|CDD\|234674
NZ_CP012297.1\|WP_074494071.1\|1461851_1462829_+\|helix-turn-helix-domain-containing-protein	unknown	unknown	gnl\|CDD\|375319
NZ_CP012297.1\|WP_003858767.1\|1464855_1465074_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074494075.1\|1470278_1471379_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|378684
NZ_CP012297.1\|WP_003858832.1\|1450358_1450574_+\|acetyl-CoA-carboxylase-biotin-carboxyl-carrier-protein-subunit	unknown	unknown	gnl\|CDD\|223585
NZ_CP012297.1\|WP_074494065.1\|1452983_1453934_-\|amino-acid-ABC-transporter-permease	unknown	unknown	gnl\|CDD\|223836
NZ_CP012297.1\|WP_060564485.1\|1462831_1463707_+\|aldo/keto-reductase	unknown	unknown	gnl\|CDD\|381353
NZ_CP012297.1\|WP_074494101.1\|1446627_1448211_+\|DAK2-domain-containing-protein	unknown	unknown	gnl\|CDD\|224378
NZ_CP012297.1\|WP_074494072.1\|1464079_1464859_-\|class-I-SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|369777
NZ_CP012297.1\|WP_011014303.1\|1465110_1466571_+\|30S-ribosomal-protein-S1	unknown	unknown	gnl\|CDD\|236126
NZ_CP012297.1\|WP_003858826.1\|1452215_1452980_-\|amino-acid-ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|224051
NZ_CP012297.1\|WP_074494070.1\|1460414_1461815_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|129794
NZ_CP012297.1\|WP_074494066.1\|1453976_1454981_-\|ABC-transporter-substrate-binding-protein	unknown	unknown	gnl\|CDD\|270225
NZ_CP012297.1\|WP_003858829.1\|1450573_1451158_+\|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD	unknown	unknown	gnl\|CDD\|223813
NZ_CP012297.1\|WP_038583867.1\|1448215_1450339_+\|ATP-dependent-DNA-helicase-RecG	unknown	unknown	gnl\|CDD\|224121

Protein	Function_ID	Function_description	E-value
NZ_CP012297.1\|WP_074494069.1\|1457775_1460418_+\|DNA-polymerase-I	gnl\|CDD\|235591	PRK05755, PRK05755, DNA polymerase I; Provisional.	0
NZ_CP012297.1\|WP_074494067.1\|1455080_1455890_+\|DUF1266-domain-containing-protein	gnl\|CDD\|377728	pfam06889, DUF1266, Protein of unknown function (DUF1266). This family consists of several hypothetical bacterial proteins of around 235 residues in length. Members of this family seem to be found exclusively in the Enterobacteria Salmonella typhimurium and Escherichia coli. The function of this family is unknown.	8.78068e-21
NZ_CP012297.1\|WP_074494074.1\|1469300_1469903_+\|dephospho-CoA-kinase	gnl\|CDD\|237808	PRK14734, coaE, dephospho-CoA kinase; Provisional.	1.41012e-112
NZ_CP012297.1\|WP_074494073.1\|1467229_1469290_+\|PTS-transporter-subunit-EIIC	gnl\|CDD\|273919	TIGR01995, beta-glucosides_PTS_EIIBCA, PTS system, beta-glucoside-specific IIABC component. This model represents a family of PTS enzyme II proteins in which all three domains are found in the same polypeptide chain and which appear to have a broad specificity for beta-glucosides including salicin (beta-D-glucose-1-salicylate) and arbutin (Hydroquinone-O-beta-D-glucopyranoside). These are distinct from the closely related sucrose-specific and trehalose-specific PTS transporters.	2.73706e-153
NZ_CP012297.1\|WP_074494068.1\|1455972_1456953_-\|DUF368-domain-containing-protein	gnl\|CDD\|224946	COG2035, COG2035, Predicted membrane protein [Function unknown].	9.90711e-79
NZ_CP012297.1\|WP_038583872.1\|1451161_1451644_+\|pantetheine-phosphate-adenylyltransferase	gnl\|CDD\|234674	PRK00168, coaD, phosphopantetheine adenylyltransferase; Provisional.	7.32226e-91
NZ_CP012297.1\|WP_074494071.1\|1461851_1462829_+\|helix-turn-helix-domain-containing-protein	gnl\|CDD\|375319	pfam17765, MLTR_LBD, MmyB-like transcription regulator ligand binding domain. This domain is found in a family of actinobacterial transcription factors. The structure shows it has a PAS domain like fold and it is bound to Myristic acid.	2.68538e-53
NZ_CP012297.1\|WP_074494075.1\|1470278_1471379_+\|hypothetical-protein	gnl\|CDD\|378684	pfam11611, DUF4352, Domain of unknown function (DUF4352). Members of these family are putative lipoproteins that fall into the Antigen MPT63/MPB63 (immunoprotective extracellular protein) superfamily.	0.00500072
NZ_CP012297.1\|WP_003858832.1\|1450358_1450574_+\|acetyl-CoA-carboxylase-biotin-carboxyl-carrier-protein-subunit	gnl\|CDD\|223585	COG0511, AccB, Biotin carboxyl carrier protein [Lipid metabolism].	3.09213e-16
NZ_CP012297.1\|WP_074494065.1\|1452983_1453934_-\|amino-acid-ABC-transporter-permease	gnl\|CDD\|223836	COG0765, HisM, ABC-type amino acid transport system, permease component [Amino acid transport and metabolism].	4.71409e-71
NZ_CP012297.1\|WP_060564485.1\|1462831_1463707_+\|aldo/keto-reductase	gnl\|CDD\|381353	cd19127, AKR_AKR5B1, AKR5B family of aldo-keto reductase (AKR). Pseudomonas putida morphine 6-dehydrogenase (M6DH) is a founding member of the aldo-keto reductase family 5 member B1 (AKR5B1). M6DH (EC 1.1.1.218), also called naloxone reductase, oxidizes the C-6 hydroxy group of morphine and codeine.	2.55694e-141
NZ_CP012297.1\|WP_074494101.1\|1446627_1448211_+\|DAK2-domain-containing-protein	gnl\|CDD\|224378	COG1461, COG1461, Predicted kinase related to dihydroxyacetone kinase [General function prediction only].	0
NZ_CP012297.1\|WP_074494072.1\|1464079_1464859_-\|class-I-SAM-dependent-methyltransferase	gnl\|CDD\|369777	pfam08241, Methyltransf_11, Methyltransferase domain. Members of this family are SAM dependent methyltransferases.	1.13315e-24
NZ_CP012297.1\|WP_011014303.1\|1465110_1466571_+\|30S-ribosomal-protein-S1	gnl\|CDD\|236126	PRK07899, rpsA, 30S ribosomal protein S1; Reviewed.	0
NZ_CP012297.1\|WP_003858826.1\|1452215_1452980_-\|amino-acid-ABC-transporter-ATP-binding-protein	gnl\|CDD\|224051	COG1126, GlnQ, ABC-type polar amino acid transport system, ATPase component [Amino acid transport and metabolism].	5.13474e-153
NZ_CP012297.1\|WP_074494070.1\|1460414_1461815_-\|MFS-transporter	gnl\|CDD\|129794	TIGR00711, Uncharacterized_MFS-type_transporter_YhcA, drug resistance transporter, EmrB/QacA subfamily. This subfamily of drug efflux proteins, a part of the major faciliator family, is predicted to have 14 potential membrane-spanning regions. Members with known activities include EmrB (multiple drug resistance efflux pump) in E. coli, FarB (antibacterial fatty acid resistance) in Neisseria gonorrhoeae, TcmA (tetracenomycin C resistance) in Streptomyces glaucescens, etc. In most cases, the efflux pump is described as having a second component encoded in the same operon, such as EmrA of E. coli. [Cellular processes, Toxin production and resistance, Transport and binding proteins, Other].	1.84984e-47
NZ_CP012297.1\|WP_074494066.1\|1453976_1454981_-\|ABC-transporter-substrate-binding-protein	gnl\|CDD\|270225	cd01004, PBP2_MidA_like, Mimosine binding domain of ABC-type transporter MidA and similar proteins; the type 2 periplasmic binding protein fold. This subgroup includes the periplasmic binding component of ABC transporter involved in uptake of mimosine MidA and its similar proteins. This periplasmic binding domain belongs to the type 2 periplasmic-binding fold protein (PBP2) superfamily, whose members are involved in chemotaxis and uptake of nutrients and other small molecules from the extracellular space as a primary receptor. PBP2 typically comprises of two globular subdomains connected by a flexible hinge and bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two receptor cytoplasmically-located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis.	6.73483e-75
NZ_CP012297.1\|WP_003858829.1\|1450573_1451158_+\|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD	gnl\|CDD\|223813	COG0742, COG0742, N6-adenine-specific methylase [DNA replication, recombination, and repair].	3.36246e-65
NZ_CP012297.1\|WP_038583867.1\|1448215_1450339_+\|ATP-dependent-DNA-helicase-RecG	gnl\|CDD\|224121	COG1200, RecG, RecG-like helicase [DNA replication, recombination, and repair / Transcription].	0

>NZ_CP012297.1|WP_074494068.1|1455972_1456953_-|DUF368-domain-containing-protein
MSATNPDARDVQHVYPIKTKKTPLAVIFNIIHGGLIGMAELVPGISGGTVALILGLYERALHNGDLLIDLIKVLIKDRSKVKEAAAKIDWWFLGAIGVGMVVMVFSMSSILHTVVEDYPEITRGLFLGMVAVSILVPLGMMDMRDAKKRLAIVIPLFIICAMLGFFGTSFTSAPRTDPSLIFVFICAAIAVCALVLPGVSGSFFLLAVGMYAPIMESLSNRDLSVIGVFLLGALTGVILFVKVLSYVLEHHRTITLTIMAGLMLGSLRALWPWQDGDANLLAPGDNAVMIFSIVILGGAIVAALMFAERVSSKNVDSEIVAEEQPR
>NZ_CP012297.1|WP_074494067.1|1455080_1455890_+|DUF1266-domain-containing-protein
MSSQQTIFIILLFAAVILISIVMITAAFKTRKKRFVARAEGMANPTIPAPTVPWQRFAGALAALYARPEWHKTRGAKRVYSAEQTYFGFVSAMPLGMVQNMLQTDWGVKKSEHAVDQLSKGVEVIVGVAAGNWRKNGVSPAQVEEAGQRLAAEGLAHPHFVEFQKQLQQADPNAEYDLDVLAFDIARVANLLRWAAYTDLLLPAEARWFQDQLGIAAAVSFGSWEEYGERYVRGLQKNFKGGNKPYIEGERWLNTEAESPWKTQKWISA
>NZ_CP012297.1|WP_074494066.1|1453976_1454981_-|ABC-transporter-substrate-binding-protein
MAGSILPMIESFTRLRISQTPPLKRLLHSTLRFPKIPKRAVAATVGIVATSFTLASCVTNEEQGNPDGWEQIVPDPVPEIQAMVPEAMAQRGVLTAGANPPFPPFEFKDSDGQIIGVEMDLVRAMAGVMGLEFSPQEQDFSLILPSVQAGTLDIGASGFTDNEERRENFDFIDFLYAGVQWAQATDRETPIDPENACGLTVAVQRTTVAETDDVRPRSAQCEAEGKEPITILSYETADTAATALILGRADALAADSPVSAWAAERSEGRIEVVGDMYLAAPFGFAFPLESDLTPAAAAAFQHLIDTGDYQRIMAQWGIEEGLLDEALINEQPLK
>NZ_CP012297.1|WP_074494065.1|1452983_1453934_-|amino-acid-ABC-transporter-permease
MSDLNQGPGASTAQPTPIEAKPLRHPGRWVGAAILLALLAWFIISALNNDAYGWNTYRSYLFDTRVATAALHTIALTILSMIIGVVLGAVLAVMRMSGNPVMQGVAWLYLWIFRGTPIYVQLVFWGLLGSLYQSINLGFAEIDLQSLLSNMFLLAVIGLGLNEAAYMAEIVRSGIQAVPEGQMEASKALGMNWSMTMRRTILPQAMRIIIPPTGNELISMLKTTSLVVAIPYSLELYGRSMDIAYSLFEPVPMLLVAASWYLVITSILMVGQYYLEKHFEKGSTRTLTARQLAALADAEGAIPGNVTVVPETSKEN
>NZ_CP012297.1|WP_003858826.1|1452215_1452980_-|amino-acid-ABC-transporter-ATP-binding-protein
MSQLMIDAQQVCKNYGRLEVLKGIDLQVPKGTVTCLIGPSGSGKSTMLRCVNHLEKVNAGRLYVDGDLIGYRERDGVLYEISEKDAAKQRSDIGMVFQNFNLFPHRTVIENIIEAPIHVKKQPESKARARAMELLEQVGLAHKADAYPVQLSGGQQQRVAIARAVAMEPKLMLFDEPTSALDPELVGEVLRVMKQLADDGMTMLVVTHEMGFAHEVADQVVFMADGVVVEAGTPEQVLDNPKEQRTKDFLSSLL
>NZ_CP012297.1|WP_038583872.1|1451161_1451644_+|pantetheine-phosphate-adenylyltransferase
MKAVCPGSFDPITLGHLDIVTRAAAQFSEVTILVTANPNKNTGLFTVAERMDLIRESTAHLDNVKVDTWASLLVDYTTEHGIGALVKGLRSSLDYEYELPMAQMNRRLTGVDTFFLLTDEKYGYVSSTLCKEVARFGGDVSGLLPEVVAKAVTEKYSNQH
>NZ_CP012297.1|WP_003858829.1|1450573_1451158_+|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD
MGQTRIISGDARGRKIEVPPAGTRPTSDRAREGLFSSLQVRFGFEGQRVLDIFAGSGALGLEAASRGADEVVLVESNPKAVEVIRRNVDVVKHPRVTVAEMKASTYLASAPDKFFTMVLADPPYELADDAVTEMLTALTPKLLDGAAVVVERHVDSPETAWPAWLVPTTQKLKKRTYGIARMDMAVFDESLLQE
>NZ_CP012297.1|WP_003858832.1|1450358_1450574_+|acetyl-CoA-carboxylase-biotin-carboxyl-carrier-protein-subunit
MKIYAPFAGIVHYFVDEGDPVETGMQLGTVETIKLEAPIMAPGPGIVAKVSFDDFSDVTGGDELLELEAKN
>NZ_CP012297.1|WP_038583867.1|1448215_1450339_+|ATP-dependent-DNA-helicase-RecG
MLGWHDERLLKDILPAKEATAIKKALGYTTAEELLRHHVRKYSHHGSGVGIGDATEGDLVTIVGQVAFAKQSYTQSGKMLYKVTVLTETERIGISFFGAKHIPRLLPEGTRALFTGKVKFFRNEPQLSHPEFIVIPDPGSGRRLTATGGMKSLAAYGDVEEVALRLVDREYIPIYAGTATMTTWRIMAAVQRVLETMPVIKEPLSVVPEGMPSFDEAIRGIHDPGHESPSTFINRLKYNEALSLATVMAIRRADTKNRKAPPMPRALKGHQHMLIDALNFQLTAGQKQVIREISADIEQRVPMSRLLQGEVGSGKTIVSLIAMLQAIDSGRQCAMLAPTEVLATQHARSLSKTLDDAGLDINVVLLTGSMPTGAKKEALLEIISGDADIVVGTHALIQDTVEFFDLGLVVVDEQHRFGVEQRDQLRTKGREGLTPHLLVMTATPIPRTIAMTVFGDLAVSTLRELPGGRRPIQTSVIPDHKPGWVKRGWERIGEEVLAGRQAYVVCPRIEGEGGVLEIHAYLSEQVYPGLNVGMLHGRMDTDLKDSVMQEFAQGEIDILVATTVIEVGIDVANATVMLIREAERFGVSQIHQLRGRVGRGQHDSLCLLHTTFDEDSPQGQRLAAISTTTDGFQLSELDLQVRQEGDVLGTRQSGSDTKLRHLSFISDQKIIERALIDATELVAASRSRALELVSDIAMINQEYLEKS
>NZ_CP012297.1|WP_074494101.1|1446627_1448211_+|DAK2-domain-containing-protein
MDAAGVLEWARTAVEQLSERRAEINALNVFPVPDADTGSNMTYTMTAALDEALKLGESGDVARITEALAVGSVRGARGNSGVVLSQVLRAIAQAAADGVIDGHTIQEALSIARSLVDRAITDPVEGTVVTVLRSAAIEAEHLVEAGHTALPDVVNAAVKAARTALARTPSQLAVLREAGVVDAGGQGLVILLESLAEQINGNPPHHPSHHSEPAEEPSFHGKTGDLEVMFYIACDSAQTLDALHNELETLGDSLLIARETDTCGTVHIHSRRAGEVIQKAFAAGDVSELRLEILPDTPGSFTEEPRRVLMAVAPDGLVAELYRSAGVKVVARNIAQSKSDDVVAKIVSIARKSGADEVILLPNGLLTKRELVSIERSSHAFEQSVVILPTATLVAGLAAVSVHEPAQPLAVDSYAMAEAAGAMRTATIRAAASAALTQAGACSKGDLLSFIGPEIALVSEELNDALSRTALRLLDGSSEQITLLIAQDRQSAFDEDVFRRGLGTHTDVEITVYPATGMENLVEIGVE
>NZ_CP012297.1|WP_074494069.1|1457775_1460418_+|DNA-polymerase-I
MLIDGHSMAFRAFFALPAENFSTSGGQATNAVYGFLSMLSTLLKDEQPTHVAVAFDVGRKTFRTDMFPAYKAQRDATPPEFKGQVEILKEVLSTLGITTIEKIDFEADDVIATLSVAAKPLGFKTLIVTGDRDSFQLVNDTTTVLYPMKGVSVLHRFTPEAVEEKYGLTPRQYPEFAALRGDPSDNLPNIPGVGEKTATKWIAQYETLDNLLDHADEIKGKVGASLRERIEQVRMNRKLTEMVKDLELPLGPDDFDMKPVQVAEVAAKFDDLEFGTNLRERVLAVVKAEGSVAPVEEVEAEQVVVDTQSLAQWLPARAGQALALALTGVAKPAGGDAYALAIADTKRHAVLVDLADISAEDEKALATWLASEDPKMLHGAKAAYHMLAGRGFELNGVVHDTAIAAYLLRPGQRTYELADVYQRHLQRQLSTNDNGGQLTLLDAADDQSLVDDVIAILELSEELTKQLQEIQAFELYHDLEIPLSGILARMEAIGIAVDVATLEEQLKTFIGQVAQEEEAARELAEDPTLNLSSPKQLQVVLFETFGMPKTKKTKTGYSTAAAEIEALAIKNPHPFLDHLLAHRQYQKMKTTLEGLIREVAPDGRIHTTFNQTVASTGRLSSTDPNLQNIPVRTEAGRKIRSGFVVGEGYETLLTADYSQIEMRVMAHLSQDPGLIEAYREGEDLHNYVGSKVFNVPIDGVTPELRRQVKAMSYGLVYGLSAFGLSQQLSIPAGEAKQIMESYFERFGGVQRYLREIVEEARKAGYTETLFGRRRYLPELTSDNRVARENAERAALNAPIQGTAADIIKVAMIRVDRSLKEAAVKSRVLLQVHDELVVEVAAGELEQVREILEREMDNAIKLSVPLEVSAGDGVNWDAAAH
>NZ_CP012297.1|WP_074494070.1|1460414_1461815_-|MFS-transporter
MILSIVLLGYFMILLDTSIVITGLPAIGSELGIDPVHLSWVQSSYTLVFGALLLLGARAGDIFGRKKVLYIGLALFAASSLAIALSPNAAVLIGARVVQGAGAAIIAPATLALITEFFPEGPARLRATSAYGAVAGIGVAAGLVIGGVFADLLSWRIGFFINVPIAAVLAYMVHKAIPATFSRPGSLDIFGAITSTAGIAAVLYAITRSADYSWTDPFVLISLVLGIAVFIWFLRHESSAKEPLLPLGLFKNRRRNTILASRFLLVGSVMSFFFFATQLFQDTMGMNALRAGLAFIPLSLLQFASAAMVPRLSRAGVSDSMLTVIGFAIMVIGMAGLAFVPNTMIALILPIVLVGFGQGFAFGPMTALAVQGAPKDQSGAVSGLVNSLHQIGGTFGLGVFSSLAVAVIGHDATSEMISDRAHFGFLLSTVTLTLATIFAVTLLKRHETRKSSERPPRRNEERAVTP
>NZ_CP012297.1|WP_074494071.1|1461851_1462829_+|helix-turn-helix-domain-containing-protein
MIAYAGTTGTCLKVSPNAYVEDIDVHADTREFLTSRRNRLTPKDAGLPIYHGKRRVPGLRREEVAMLAGVSVDYYTRLERGNLSGVSEQVLSALATALQLDDAETQHLFDLAKLSNSPASRRKRTPAPKSVLRPEVLRILNSMHDIPAYIRSESRDLLAANTFGRALYAPLYESTVSDGISGEPGSINVARFTFLDPAAREFFPEWERTSADLVASLRTVAAQRPNDTLFSNLIGELVTKSEVFAQMWADHNVRMHRTGSKKIVHPLVGEMELDFETLDLPADPDIALVVYSAAEGSTSAMNLQLLANWTGNDSPSLSTELGDTI
>NZ_CP012297.1|WP_060564485.1|1462831_1463707_+|aldo/keto-reductase
MTFTLNNGLAIPDIGFGVFQTPPDETRNSVNAALEAGYRHIDTAAAYGNEREVGEAIAASGIGRDEITIETKIWVTDYGFEETLHAFDKATGKLGVDTLDILILHQAVPSSFDRTIAAYKALEKLLFDGAVRAIGVSNFMPEHLDKLLLETSIVPALNQIECHPYFQQRDVLARNEQLGILTQAWSPIGGITFYRDGQLPSTLENEVIAGIAAEVGKTPAQVMLRWHLQRGRHAIPKSVTPSRIVENFEIFDFELSDEQLQQIDALNTDLRGGPEPENITMENYYREIPEA
>NZ_CP012297.1|WP_074494072.1|1464079_1464859_-|class-I-SAM-dependent-methyltransferase
MSQFSQANRYWWDVDAADYHERHPSYLGTDSAHGEFYWCPEMLHEKDVRLLGTPAALSGKKILEIGCGSAPCARWLANDVPDAFVTAFDISSQMLKYAGHDHNVHLAQADAMSLPYADSSFDVVFSVFGAIPFVEDSGALMKEIARVLKPGGRLIFSITHPMRWIFLDDPGPAGLTAITSYFDQRGYVEEDEETGALSYAEQHRTMSARINELIDASLHLDHLIEPEWPDELEENWGQWSPLRGKLFPGTAIFLATYRP
>NZ_CP012297.1|WP_003858767.1|1464855_1465074_-|hypothetical-protein
MDRMQYLSNALYRRGFDLTFRLNVLSYMNTPIHDATTRLINSTPFAQLEQIEWQKWAHTILMGPMGKPQATN
>NZ_CP012297.1|WP_011014303.1|1465110_1466571_+|30S-ribosomal-protein-S1
MPTNNAPQVAINDIGSAEDFLAAIDATIKYFNDGDIVEGTVVKVDRDEVLLDIGYKTEGVIPSRELSIKHDVDPDEVVEVGDQIDALVLTKEDKEGRLILSKKRAQYERAWGAIEELKEKDEPVTGTVIEVVKGGLIIDIGLRGFLPASLVEMRRVRDLDPYIGQELEAKIIELDKNRNNVVLSRRAFLEQTQSEVRSEFLHQLQKGQVRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVTVGDEVTVEVLEVDLDRERVSLSLKATQEDPWRVFARTHAVGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAQRHVEVPDQVVAVGEEVMVKVIDIDLERRRISLSLKQADEDYTEEFDPSKYGMADSYDEQGNYIFPEGFDAETNEWLEGFDEQRQAWEARYAESERRFTAHTAQIERRRQQAEEAAAEAPAGNYSTDSAEDAPAAEAVEESAGSLASDEQLAALREKLAGN
>NZ_CP012297.1|WP_074494073.1|1467229_1469290_+|PTS-transporter-subunit-EIIC
MASKLTTTSQHILENLGGPDNITSMTHCATRLRFQVKDQSIVDQQEIDSDPSVLGVVPQGSTGMQVVMGGSVANYYQEILKLDGMKHFADGEATESSSNKEYGGVRGKYSWIDYAFEFLSDTFRPILWALLGASLIITLLVLADTFGLQDFRAPMDEQPDTYVFLHSMWRSVFYFLPIMVGATAARKLGANEWIGAAIPAALLTPEFLALGSAGDTVTVFGIPMVLNDYSGQVFPPLIAAIGLYWVEKGLKKIIPEAVQMVFVPFFSLLIMIPATAFLLGPFGIGVGNGISNLLEAINNFSPFILSIVIPLLYPFLVPLGLHWPLNAIMIQNINTLGYDFIQGPMGAWNFACFGLVTGVFLLSIKERNKAMRQVSLGGMLAGLLGGISEPSLYGVLLRFKKTYFRLLPGCLAGGIVMGIFDIKAYAFVFTSLLTIPAMDPWLGYTIGIAVAFFVSMFLVLALDYRSNEERDEARAKVAADKQAEEDLKAEANATPAAPVAAAGAGAGAGAGAAAGAAGAATAVAAKPKLAAGEVVDIVSPLEGKAIPLSEVPDPIFAAGKLGPGIAIQPTGNTVVAPADATVILVQKSGHAVALRLDSGVEILVHVGLDTVQLGGEGFTVHVERRQQVKAGDPLITFDADFIRSKDLPLITPVVVSNAAKFGEIEGIPADQANSSTTVIKVNGKNE
>NZ_CP012297.1|WP_074494074.1|1469300_1469903_+|dephospho-CoA-kinase
MLRIGLTGGIGSGKSTVADLLSSEGFLIVDADQVARDIVEPGQPALAELAEAFGQDILKPDGTLDRAGLAAKAFVSEEQTALLNAITHPRIAEESARRFNEAEDQGAKVAVYDMPLLVEKGLDRKMDLVVVVDVDVEERVRRLVEKRGLTEDDVRRRIASQVPDDVRLKAADIVVDNNGTLEDLHAEASKLIAEILGRVN
>NZ_CP012297.1|WP_074494075.1|1470278_1471379_+|hypothetical-protein
MKDYAVHTRGLVSLLSLIFLFVLSGCGGNATTADEAAESDVVTSSSAPPSKRALDVGEAVEIPGVVLTVNSVTQSDQLMLYSEGSARGSEPREQRNAASGEKFVLVDTTVKNSSSDPWDLSCGHVLQTWLLEDELDDQQGDQEKKFSPIDNLDQISGNPECGVLLEVGTEIEMTWSFTIPDDIEITHFGFSLSDSTSNDLAIISLGGAIETSSAITTTEVIAPENDTETLLEITPVDCQVGLGPIVTSWSDGTVGGWSQHCQDVHDEVLAGEVAANTPVCDGVVCTYPSGATMPDPNAPQIPSDTSGAVCDENQCVYPNGYIARIGDPNVPNYLKPGNSPWVQGQIDFQNCLDSGKTIEQCREELN

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012297_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012297_4

1823532-1823632

Orphan

Consensus_repeat	Method
GCGGGTGAGCCGGACCCTGACGA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012297_4

>merge|NZ_CP012297|4|1823532-1823632|CRISPRCasFinder
GCGGGTGAGCCGGACCCTGACGAGCTTGCCGAGACGGACAGGGCGGAGAAAGATTTCGGGGAGCTCAGTGAGTCCCTCGCGGGTGAGCCGGACCCTGACGA

>NZ_CP012297|4|4|1823532-1823632|CRISPRCasFinder
GCGGGTGAGCCGGACCCTGACGA	GCTTGCCGAGACGGACAGGGCGGAGAAAGATTTCGGGGAGCTCAGTGAGTCCCTC
GCGGGTGAGCCGGACCCTGACGA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012297.1\|WP_074491901.1\|1841041_1841494_+\|glycerate-kinase	unknown	unknown	gnl\|CDD\|224840
NZ_CP012297.1\|WP_074491914.1\|1829176_1830868_+\|tetratricopeptide-repeat-protein	unknown	unknown	gnl\|CDD\|315987
NZ_CP012297.1\|WP_074491930.1\|1815747_1816290_-\|HIT-domain-containing-protein	unknown	unknown	gnl\|CDD\|238606
NZ_CP012297.1\|WP_074491911.1\|1832273_1834106_+\|site-specific-DNA-methyltransferase	unknown	unknown	gnl\|CDD\|225100
NZ_CP012297.1\|WP_074491926.1\|1819959_1820508_-\|copper-chaperone-PCu(A)C	unknown	unknown	gnl\|CDD\|225403
NZ_CP012297.1\|WP_074491932.1\|1814100_1815066_-\|phosphatidylinositol-mannoside-acyltransferase	unknown	unknown	gnl\|CDD\|236131
NZ_CP012297.1\|WP_074491905.1\|1839330_1840479_-\|tyrosine-type-recombinase/integrase	unknown	unknown	gnl\|CDD\|271189
NZ_CP012297.1\|WP_074491907.1\|1836860_1839203_+\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|372509
NZ_CP012297.1\|WP_074492031.1\|1841721_1842069_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074491922.1\|1823115_1823340_+\|helix-turn-helix-domain-containing-protein	unknown	unknown	gnl\|CDD\|378935
NZ_CP012297.1\|WP_074491934.1\|1813014_1814100_-\|glycosyltransferase-family-4-protein	unknown	unknown	gnl\|CDD\|340831
NZ_CP012297.1\|WP_003859882.1\|1815088_1815748_-\|CDP-alcohol-phosphatidyltransferase-family-protein	unknown	unknown	gnl\|CDD\|223632
NZ_CP012297.1\|WP_145832272.1\|1826430_1828239_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|237110
NZ_CP012297.1\|WP_003859878.1\|1818724_1819933_-\|Dyp-type-peroxidase	unknown	unknown	gnl\|CDD\|225393
NZ_CP012297.1\|WP_074491928.1\|1816393_1818454_-\|threonine--tRNA-ligase	unknown	unknown	gnl\|CDD\|237050
NZ_CP012297.1\|WP_074491918.1\|1825582_1825900_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012297.1\|WP_074491909.1\|1834109_1836674_+\|DEAD/DEAH-box-helicase-family-protein	unknown	unknown	gnl\|CDD\|368155
NZ_CP012297.1\|WP_074491899.1\|1842107_1842806_+\|pyrimidine-reductase-family-protein	unknown	unknown	gnl\|CDD\|184482
NZ_CP012297.1\|WP_074491924.1\|1820523_1821114_-\|copper-resistance-protein-CopC	unknown	unknown	gnl\|CDD\|225247
NZ_CP012297.1\|WP_003855892.1\|1812553_1813018_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP012297.1\|WP_074491901.1\|1841041_1841494_+\|glycerate-kinase	gnl\|CDD\|224840	COG1929, COG1929, Glycerate kinase [Carbohydrate transport and metabolism].	3.86661e-52
NZ_CP012297.1\|WP_074491914.1\|1829176_1830868_+\|tetratricopeptide-repeat-protein	gnl\|CDD\|315987	pfam13424, TPR_12, Tetratricopeptide repeat.	9.65627e-11
NZ_CP012297.1\|WP_074491930.1\|1815747_1816290_-\|HIT-domain-containing-protein	gnl\|CDD\|238606	cd01275, FHIT, FHIT (fragile histidine family): FHIT proteins, related to the HIT family carry a motif HxHxH/Qxx (x, is a hydrophobic amino acid), On the basis of sequence, substrate specificity, structure, evolution and mechanism, HIT proteins are classified into three branches: the Hint branch, which consists of adenosine 5' -monophosphoramide hydrolases, the Fhit branch, that consists of diadenosine polyphosphate hydrolases, and the GalT branch consisting of specific nucloside monophosphate transferases. Fhit plays a very important role in the development of tumours. Infact, Fhit deletions are among the earliest and most frequent genetic alterations in the development of tumours.	4.5047e-56
NZ_CP012297.1\|WP_074491911.1\|1832273_1834106_+\|site-specific-DNA-methyltransferase	gnl\|CDD\|225100	COG2189, COG2189, Adenine specific DNA methylase Mod [DNA replication, recombination, and repair].	8.02116e-26
NZ_CP012297.1\|WP_074491926.1\|1819959_1820508_-\|copper-chaperone-PCu(A)C	gnl\|CDD\|225403	COG2847, COG2847, Copper(I)-binding protein [Inorganic ion transport and metabolism].	1.16431e-35
NZ_CP012297.1\|WP_074491932.1\|1814100_1815066_-\|phosphatidylinositol-mannoside-acyltransferase	gnl\|CDD\|236131	PRK07920, PRK07920, lipid A biosynthesis lauroyl acyltransferase; Provisional.	1.64115e-164
NZ_CP012297.1\|WP_074491905.1\|1839330_1840479_-\|tyrosine-type-recombinase/integrase	gnl\|CDD\|271189	cd01189, INT_ICEBs1_C_like, C-terminal catalytic domain of integrases from bacterial phages and conjugate transposons. This family of tyrosine based site-specific integrases is has origins in bacterial phages and conjugate transposons. One member is the integrase from Bacillus subtilis conjugative transposon ICEBs1. ICEBs1 can be excised and transfered to various recipients in response to DNA damage or high concentrations of potential mating partners. The family belongs to the superfamily of DNA breaking-rejoining enzymes, which share the same fold in their catalytic domain and the overall reaction mechanism. The catalytic domain contains six conserved active site residues. Their overall reaction mechanism involves cleavage of a single strand of a DNA duplex by nucleophilic attack of a conserved tyrosine to give a 3' phosphotyrosyl protein-DNA adduct. In the second rejoining step, a terminal 5' hydroxyl attacks the covalent adduct to release the enzyme and generate duplex DNA.	1.07944e-16
NZ_CP012297.1\|WP_074491907.1\|1836860_1839203_+\|AAA-family-ATPase	gnl\|CDD\|372509	pfam13166, AAA_13, AAA domain. This family of domains contain a P-loop motif that is characteristic of the AAA superfamily. Many of the proteins in this family are conjugative transfer proteins. This family includes the PrrC protein that is thought to be the active component of the anticodon nuclease.	3.98608e-53
NZ_CP012297.1\|WP_074491922.1\|1823115_1823340_+\|helix-turn-helix-domain-containing-protein	gnl\|CDD\|378935	pfam12728, HTH_17, Helix-turn-helix domain. This domain is a DNA-binding helix-turn-helix domain.	0.000451492
NZ_CP012297.1\|WP_074491934.1\|1813014_1814100_-\|glycosyltransferase-family-4-protein	gnl\|CDD\|340831	cd03801, GT4_PimA-like, phosphatidyl-myo-inositol mannosyltransferase. This family is most closely related to the GT4 family of glycosyltransferases and named after PimA in Propionibacterium freudenreichii, which is involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIM) which are early precursors in the biosynthesis of lipomannans (LM) and lipoarabinomannans (LAM), and catalyzes the addition of a mannosyl residue from GDP-D-mannose (GDP-Man) to the position 2 of the carrier lipid phosphatidyl-myo-inositol (PI) to generate a phosphatidyl-myo-inositol bearing an alpha-1,2-linked mannose residue (PIM1). Glycosyltransferases catalyze the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. The acceptor molecule can be a lipid, a protein, a heterocyclic compound, or another carbohydrate residue. This group of glycosyltransferases is most closely related to the previously defined glycosyltransferase family 1 (GT1). The members of this family may transfer UDP, ADP, GDP, or CMP linked sugars. The diverse enzymatic activities among members of this family reflect a wide range of biological functions. The protein structure available for this family has the GTB topology, one of the two protein topologies observed for nucleotide-sugar-dependent glycosyltransferases. GTB proteins have distinct N- and C- terminal domains each containing a typical Rossmann fold. The two domains have high structural homology despite minimal sequence homology. The large cleft that separates the two domains includes the catalytic center and permits a high degree of flexibility. The members of this family are found mainly in certain bacteria and archaea.	4.67757e-61
NZ_CP012297.1\|WP_003859882.1\|1815088_1815748_-\|CDP-alcohol-phosphatidyltransferase-family-protein	gnl\|CDD\|223632	COG0558, PgsA, Phosphatidylglycerophosphate synthase [Lipid metabolism].	8.92666e-26
NZ_CP012297.1\|WP_145832272.1\|1826430_1828239_+\|hypothetical-protein	gnl\|CDD\|237110	PRK12472, PRK12472, hypothetical protein; Provisional.	3.88164e-05
NZ_CP012297.1\|WP_003859878.1\|1818724_1819933_-\|Dyp-type-peroxidase	gnl\|CDD\|225393	COG2837, COG2837, Predicted iron-dependent peroxidase [Inorganic ion transport and metabolism].	6.27399e-120
NZ_CP012297.1\|WP_074491928.1\|1816393_1818454_-\|threonine--tRNA-ligase	gnl\|CDD\|237050	PRK12305, thrS, threonyl-tRNA synthetase; Reviewed.	0
NZ_CP012297.1\|WP_074491909.1\|1834109_1836674_+\|DEAD/DEAH-box-helicase-family-protein	gnl\|CDD\|368155	pfam04851, ResIII, Type III restriction enzyme, res subunit.	5.21641e-13
NZ_CP012297.1\|WP_074491899.1\|1842107_1842806_+\|pyrimidine-reductase-family-protein	gnl\|CDD\|184482	PRK14059, PRK14059, pyrimidine reductase family protein.	6.79073e-99
NZ_CP012297.1\|WP_074491924.1\|1820523_1821114_-\|copper-resistance-protein-CopC	gnl\|CDD\|225247	COG2372, CopC, Uncharacterized protein, homolog of Cu resistance protein CopC [General function prediction only].	4.0116e-42

>NZ_CP012297.1|WP_074491922.1|1823115_1823340_+|helix-turn-helix-domain-containing-protein
MANATPTLPSITSDDLLRTFRREDVCERLGISVRTLDRLLARGELKTVPRTRGKGRTTLITAASLYDYIYGGER
>NZ_CP012297.1|WP_074491924.1|1820523_1821114_-|copper-resistance-protein-CopC
MASEKNLKLRTLVAAAGVLGVGAMSMLVAPQAAAHDVVVDSNPENGSVVDEFPETIELDFSGIPQDLFTTVALSNADSGEVLTSGTPQLDGQHLSYEVPSDVQTGAGNYILGFQITSSDGHATKGSISFEVTGSAETTTESAATTDTSETTEAETTETADETSGIPAPWNWVLSIVAVLVVASAIVMMIAKNRNQK
>NZ_CP012297.1|WP_074491926.1|1819959_1820508_-|copper-chaperone-PCu(A)C
MKKFFVAGAVLSSALVMAACSPANQSDSTSTSVETTSSSSAEVSDAVITTENAVVRASVEDSDMTAVFATLVNNSDAEVNVTGFTANVDAASFEVHEVVDGVMQEKPGGFVIPAGESIELAPGGDHLMIMGLANPIEAGDEVTVTLELADGSEVKLDPIPARTIAAGDEDYGDLGTEGHEGH
>NZ_CP012297.1|WP_003859878.1|1818724_1819933_-|Dyp-type-peroxidase
MVSRRGFLGGAGLIAGASALAGCSAGENEPDGASISLKGQVVEFDGRHQAGIATPHQANLNLVAFTLRAGVDRAGVTRLMRVWTEDARALCAGETPLGSLEPEMVTSPANLTITCGFGASLFDVTQQVDLRPEWLKPIPEFERDQLRPEWGEADLVLQICSDDPVTLSHATRHMIRSGVDYAATRWVQQGFMNAHGVNETDETPRNLFGQKDGTVNPRTDDEIQQTAWISEGPDWAIDGSCMVVRRIAMNLDEWEILDRPSREVSVGRTLDTGAPLSGGDEFSEADYSARDSYGLPLIDPASHMARSRAPESNPEQVILRRVFNYDLPPDPTSEELSNAGLVFICFQKNPDLQFTPIQQRLDEQDRLNQWITHIGSAVFFIPPGTDPNDSSRDDFWGAGLLL
>NZ_CP012297.1|WP_074491928.1|1816393_1818454_-|threonine--tRNA-ligase
MNTTDTAVANLVVFEVPAGTAIGAAMRELDLPNKGPEAIVCAKDAEGQLKDLSHVPEATATFTAVPANTDDGRAVIRHSCAHVLAQAVQAEFPGTKLGIGPAIENGFYYDFDVAEPFTPEDLKTIEKRMKKIIKTGQKFERRVYESAEAAAEELKNEPYKLELIQDKGNVDPNSDEATEVGAGELTAYDNVNPRTSEVEWSDLCRGPHIPTTRYIPAFALTRSSAAYWRGDQDNAGLQRIYGTAWEDKESLDAYQTMLAEAEKRDHRRLGTELDLFSFPDDLGSGLPVFHPNGGIVRNEMEDHSRRRHIAAGYSFVNTPHITKQDLFERSGHLGFYKDGMFPPMQVDAEFDEDGNVTKPGQEYYLKPMNCPMHNLIFDSRGRSYRELPLRLFEFGNVYRYEKSGVIHGLTRARGFTQDDAHIYCTEDQLEAELTSVLDFILSLLRDYGLDDFYLELSTRDPKKSVGSDEIWERSTEILNRVATNSGLELVPDPEGAAFYGPKISVQARDAIGRTWQMSTVQLDFNMPERFNLEYTSSDGSKQQPIMIHRALFGSIERFFGVLLEHYAGAFPAWLAPHQVMGIPVADDCIPHLETITAQLRQKGIRADVDTSDDRMQKKIRNHTTGKVPFMLLAGARDVEANAVSFRFLDGTQVNGVPVDEAIAVISSWIGDRINDQPSEDSIAARR
>NZ_CP012297.1|WP_074491930.1|1815747_1816290_-|HIT-domain-containing-protein
MSYITTRSGGKQSTTAKRDPFIEVPKMSDEDGLIVARGELVYCVLNLYPYNAGHMMVIPFRKEKNLEDLSLAESAELMLFTQTAIKALKQVSNPDAVNVGLNLGKASGGSVGDHLHVHVVPRWSGDANFMTVIDGVKVLPQTLRQTRAMLAQAWGTIDGAPGTVDPTLTSAIRTAAPKEH
>NZ_CP012297.1|WP_003859882.1|1815088_1815748_-|CDP-alcohol-phosphatidyltransferase-family-protein
MLGLHGRKPAQVIVEPVAKLMIKLKVTPNQLTLVSAGLTVGVALLLIPTGHLIWAAVLTGLFAAFDMIDGTVARMQGGGTKFGATLDATCDRITDGALFGAITWWLVYSYDAPQALVAASLVCLVASQVISYVKARGEASGFTMDGGLVERPERLIVSLVGLGLTGMGVPYAIDVALWALAAGSIYTVVQRLVMAGKSPLAKEFTKAPAGAKADYSNTK
>NZ_CP012297.1|WP_074491932.1|1814100_1815066_-|phosphatidylinositol-mannoside-acyltransferase
MKPKDFCTAENWAENLSAIGYLAGWRFVRMLPLPIARRVFDLGADLASKSGKGMGQLRANLARVVGAENVTQALVKQATRSYARYWLEAFRLPAIARDPELIARLRKGTVGLDLLDESLAAGKGVVLTLPHSGNWDMAGAFLVSHHGQFTTVAERVKPERLFEAFVEFRESLGFEVLPLTGGERPPFEKLKERLTSGGIVCLLGERDLRHSGVETTFFGEKTSMPAGPAQLAIETGAALHVVHPWFDGDSWGLSVSDAVTVDNLSDTVQRIAHLFMANITAHPADWHMLQPLWFGDLDPERLKRSRSQTDFPEPVRSQEDN
>NZ_CP012297.1|WP_074491934.1|1813014_1814100_-|glycosyltransferase-family-4-protein
MRIGMVCPYSFDEPGGVQAHILDLARTFIAQGHEVQVLGPCSADTQVPDFVVRGGSSIPIPYNGSVARLSFGPKMFKAVRTFLREGNFDVLHIHEPNSPSFSMAALRFAEGPIVATYHASSSGSKLLKAFLPVLSPMLEKVRAGIAVSEMARRWQVEQVGGDPVLIPNGVETSMFKAARQIEPNDPVEIVFLGRLDESRKGLDILLRALTRLDRPFTCTVIGGGTPREVAGINFVGRVSDEEKAAILGRADIYVAPNTGGESFGIVLVEAMAAGCAVVASDLEAFSLVTDSEAAQPAGVLFKTGSDADLAKKLQALIDDPSSRSTLIAAGLKRANAYDWSTVSTQVMAVYETIAIDKVRLG
>NZ_CP012297.1|WP_003855892.1|1812553_1813018_-|hypothetical-protein
MTLVYLLIAVVVTATVLWAYFTAQRLNRLHIRTDSARQALQAALDRRAALVGALLPDAAEASKRAEAIPLEYSRFSQRARAEREISELILKQGKTLPDSIVDAATRVELAHRFYNEAVSDTRDLRTRLMVRSFRLGGTAPLPEYFELLDTDLLT
>NZ_CP012297.1|WP_074491918.1|1825582_1825900_+|hypothetical-protein
MTTATEIQAQINAEKHAHARRLAELEQKMLTAEHDELTERITTHADTLAEDEIEALELAHIRHDVTRLKADIKVAKKVLEQVSVAGNTGQNQVISDPETGSEMIQ
>NZ_CP012297.1|WP_145832272.1|1826430_1828239_+|hypothetical-protein
MMDGAVAGMSEGYSTVLRWEGVAKADVTPRMRHNGREAEEEAGIVATHGNELINAAMTARNESYIWRDGVREPLTGPDPIGQMYAVAEERWSQAQHARLNKKTGEYTKRGTPSNAAHVAEFVLQLDPKFTGPSWSQYDDTFEDGAKDYLEKLEQRVDYFADVLERAPAGGVDVYDAHLDAEGARIELKEGREDVDRWRGTITERREATDVLLRAMIDKVHEWMDVDGTKANLVSDHIHRDETSPHAQIFAVPVGDELKLPGGVTERKLSLKQLLIGHSPTKSEAQRNYSERHDEMRNHINDVARAHGIDYVATMERVDSQRSNLGKTQLRRHRAEQLRQRVHDMQVADNVVEAGDRLKDLAEREAAVTAREEALSERETAVAGRETVVGEAEEKAAKLIATAEVEAPEIRRRARSAGEKDAEVVRADADDYSTKTKVAADQVLQKAQADARRRQEEADELVAEAERERQAAVADREAAARQRARATTALTEAEEVLASAQSVPDFDPATLDVDTRDAMKQVDADFLDRLCERNTKIAEMRKHAHGSLWSKNQAQRDLANRTVEENRRRAQQLRQSLGGPQAVGNGRNRLEPHRGRSGPQAGL
>NZ_CP012297.1|WP_074491914.1|1829176_1830868_+|tetratricopeptide-repeat-protein
MEPHDQHSDLVNYLYQRLNELNASDLSRPNVVILRGPAGTGKMQIVQDLFNRLRSSRLDSYWPELTNTNHGPVPSGGGITPPVEGPGAFTWPDNTLPTFSWWGLSCEPREHGGTFDIITAVGPQLSAHMPAYLLAYGRHAGLKHAFTDDIGTTVREVRNAALNEDDDATLTKLEELGVIESVPFIGTLTNWGAQGFQQAEKIDDNRPHPAPRDLAEMILSVTHPEFPAVVVIEDMHRTGPDLCSLVDALTSLPVSRPVVVIGTASPGASTDGHFSTWLTSATRAGRAEVRDLVGQPEADVTALWVAAKNDGQNYHFAGAIEKVRHALALVSDQTTEQAMSMRHRLGEWLAKSGQPDKAIDQFEALLEDMIRELGPDHPDTLTTRNDLAERVGKTGRAQEAIDQFEALLEDRTRILGPDHPDTLTTREDLAATIGETGRLQEAISQYESLLADATRALGTDHPITLTVRSNRAYYLSDAGRVQEAVSEHEALLRDGNRVLGPDHPDTLTVRSNRAYYLSNAGRVQEAVSEHEALLADRTRVLGPDHPHTLTTRRKLEFWRNKLD
>NZ_CP012297.1|WP_074491911.1|1832273_1834106_+|site-specific-DNA-methyltransferase
MGRRPQKLELTWFNKDQALIPTEEGKYGYTWVDPKDPRYCETHTLITEDIVRGEQSPKEDGTTYSERADLEPTEDNLLILGESGDVLEALTRVPELADKYVGQVKCVYIDPPFNTAQTFANYEDNLEHSIWLTMMRDRLIHLRQLLSDDGSIWVHLDDVENHRMRVLMDEVFGAGNFVATIAWQKRTTRENRAPMSDNQDYITIYAKKSPSVWGNTRNRLLRTDVGWNPDNDPRGNWTSSPFTAQGWRPNQMYEITTPTGEILTPPRGRCWGGIRETFDRYLLDDRVYFPKGGSGRPRIKQFVKDAPGLVPHTFWPSSEVGENDDAKKHIQDMFPGDGEVFSTPKPEKLLERIIHIATNPGDIVLDVFAGSGTTAAVAQKMGRRWVTCELVEDTMERFTRPRLEKVVRGEDPGGITLTKGERVDATTDGLPEGLSAEDAQKLTSLLNKATTDRDDLKKHPVVRELKALVKTAKSKDTINWRGGGSFTVARLSPSCFDYDPELDLVTLTEAATGSTLVESVAANLGFYLTPENRHFDGVLGRQHLAVVEGVLDDTKVDDLIAHLPQGHTLLIAATIVTEGVREHVRGFKNGSRVVNIPLDIFTYTQAQEEK
>NZ_CP012297.1|WP_074491909.1|1834109_1836674_+|DEAD/DEAH-box-helicase-family-protein
MALHVTYDENLIEELSSRFNLRNPNREALTTLVQRLNAGEYTPLGQLMLDLATGVGKTFVMAAFIEYLNRQGHRNVMVVTPNTVVQDKTVRDFSHGSERYIDGFHTPPILVTPNSAQGFSIAESTQSVFATGDASMLYVFNVQQLFPPKDSGKSQATGQEAQRRKTWRWQEEYGSLMDHLRSLDDLVVIVDEAHLFGSSAKVYRSALEELLPQATVGLTASPDKKDEIVYRYPLWRAIKDGYVKQPVLVYRNSGYDSEDRQLQDAMSLLTLKEKAYAGWRAAHSDAKPTKPLLFVVCSDVAHATETAARLRTATFTGSDVAVLQVDNEHDDAATQSFLRYLDAEHSPVRVIVSVNKLREGWDTKRIAVMCTLRAMGSDVLTQQVMGRGLRLPFGELTGVEPIDELDIISHKSFVSLLKSENVLREFGIDSDDRVDPEQVLAKPGTKHEPNVGPDTGSPTAGTPQPAATAHGGSVPAAEGITGSEARSAADVLGSKGLDDDEDIAGDEDVFQQVTVSMNPPFAGTTFLFPATTMEKTIAPFELADISTDAIVAAAKRTKNTAEYLERTRIAAATGKSGEGAITAQATDRVAVDSLRQSESEVRTELIRRVLTTGVVSNDPENRNQLTQRIVPTFMDHTGIDAWTEKAKFSAAEELRALVVAEMKQTASEAKTKTTIVPVELPIDDSFTLDFGKKILERLTVTPTSTKASTGFKEREYYGPWTKGLFEAAAFDSFSGEYRLAEILNFDPDVVWWKRLYPHEGAVVAYTPQNDYHPDFVVLAADGTHWIIEGKSQRGRDDQVVQRKKDAAEKAIRLLAGKPDYVNQAWGYLIAFEDDIATADSLADLLATGATERTR
>NZ_CP012297.1|WP_074491907.1|1836860_1839203_+|AAA-family-ATPase
MLSQLALDMPFRSLRPDTFSEDITFGKRTIIYGHNGSGKSSLAELLYQIGNAQYDESLSWTDGSGNRTKLKPGQEAPATTLSAFTKSWVEKNLSEFLDGNSAASIVTFGAEAIGAKEEQEKIEQELEKLHEAKPQIERDFREAEKATSALVRSVQDAIEGTLRDVDNRKFTKNRYTAPKVRSLLADTPPNQIDPEQHQKNLDDLAHGPRKVIHLATPPNTDWTKLRHEVGDLLVQNVESELITELLGNISLQNWLEIGLGLHSEEGSCLFCEGEVSNDRLQQLRNHFDDSRRKLQERVNTLIGEIETIRHSYQQWEKSFPNGEDFYPEVQTLFERATVRERDLLSHIKDFLDCLEENLLAKRAAPEKTGFDALPEPPIPVGEAVKEVCDHHNESANAAEKRQSETATAVLNYLLGAHSDNYQKILSAEKEKQAAFKSVAREIPEKTAFLQKIRAKQFSSQKMAACLTRDLSSVYGKHHLAIEVSGDGKSYLCRRDGMPAKHLSDGEKNTLALIYFLRQLEDESVRVLPSSRLVVIDDPSSSLDREAIFATHAWLLEALARYGQSIILTHDFEMMRLFLNSQERKVSEHQRVISHGQGKHASPLEKEKADKELIYPRISFLEMRASRDSSDNRSSKLTKISPALLKHPSEYHFLFDRVLAGIEDSNDHELLFLLPNAARRILETFTNFHVPNRPSFEQKLRKIALEDCNESYRDVYDFCNRFSHGEGRETQLVLDTHTVHHQVKRCMELLQKVAPDHYRHMCEATGRKDRDPLSESVLVRP
>NZ_CP012297.1|WP_074491905.1|1839330_1840479_-|tyrosine-type-recombinase/integrase
MARESWGIIDRLPSGRYRARYTHDGARYKAPDTFETKTQAREYLARERSDIAAGTWIHPDEREKARKQAQLTRDRAQITFGAYATRWVTTRTNGRGHPIKVSTRDEYLRLIETGRLASWSETPLAEINTAAVRNWYAEQIATGKLTAAARAYDLMKSVLKTAVEDELIETNPCRVRGGSTATTGKKVIPPTDEELDRIIDALPEIYRPVAVLAAAGGLRFGEIIALTREDITIELDDDGEVDAVRIAVTKSIAHTKRSGRVEGTTKSEAGERVIAIFGADAETIAAYAKKTAPGKRLWHATRDPNQPLPYHTFEHHWKNATAAVGSTANFHSLRHYSGTRYAQTGATLKETMARLGHSSPVAAMRYQHAGTRDDELARRAAR
>NZ_CP012297.1|WP_074491901.1|1841041_1841494_+|glycerate-kinase
MRNFADVFEQALGLTTLAQTAGAGAAGGLGFMAMALLSAEMRSGVDMILNETGGEKMLAQADLVITGEGRIDAQTLSGKAPTGIAKRARAKGIPVLAVCGQSLLDPAISNELFEDIYSLTDFESDINECIRNPLPILEGIGFNIAKHHLS
>NZ_CP012297.1|WP_074492031.1|1841721_1842069_+|hypothetical-protein
MFSFTHPLTITAVTVAIAATSLLAATTPASAACLDANGQQVGPLLVQASSENTSRVDVCSQIDLGTYWEGIDGHTGKFGILNFKYADNKFFALHIEDVTGLGLGSSDQNPTGTFG
>NZ_CP012297.1|WP_074491899.1|1842107_1842806_+|pyrimidine-reductase-family-protein
MVDILELIGPLPSVSTPELRAIVVTAINGSTTINGTSGQLGNSTDTELLLALRRWSDVVLVGSSTVKAENYGGVEVSPEIQKQRQELGQEAIPPIAVMSGSLNFDVDTRFFHEAEVPPIIITDNSDQTKQQRLVDAGAQVIEVEALTAEVGVEKLRSLGYARIDCEGGATLYGQMLAADLVDVWHHTIDPTLSGSVERPTVKGGDDAPRRFALEHVFVDDDSTLFLRYKRAK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP012297_1	1.1\|256918\|33\|NZ_CP012297\|CRISPRCasFinder	256918-256950	33	NC_005909	Pseudomonas alcaligenes plasmid pRA2, complete sequence	22369-22401	9	0.727

1. spacer 1.1|256918|33|NZ_CP012297|CRISPRCasFinder matches to NC_005909 (Pseudomonas alcaligenes plasmid pRA2, complete sequence) position: , mismatch: 9, identity: 0.727

gacaccagcgaacgaaagtgggcgggcttggtg	CRISPR spacer
ttgatccgcgaacgaacgcgggcgggcttggaa	Protospacer
   *.* ********* *.************ .

Prophage detection

Region	Region Position	Protein_number	Hit_taxonomy	Key_proteins	Att_site	Prophage annotation

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage